Exclusions for E4_PCOS_CONSORTIUM

E4_PCOS_CONSORTIUM_EXCLUSIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74 Hospital discharge: ICD-9 — 2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940 Hospital discharge: ICD-8 — 2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260 Cause of death: ICD-10 — E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74 Cause of death: ICD-9 — 2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940 Cause of death: ICD-8 — 2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260 2 out of 7 registries used, show all original rules.	62934
4. Check minimum number of events None	62934
5. Include endpoints None	62934
6. Filter based on genotype QC (FinnGen only)	60697

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	E4_PCOS_CONSORTIUM_EXCLUSIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
HD_ICD_9	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
HD_ICD_8	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
COD_ICD_9	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
COD_ICD_8	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exclusions for E4_PCOS_CONSORTIUM based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60697	56453	4244
Unadjusted period prevalence (%)	18.76	20.03	1.94
Median age at first event (years)	45.52	45.58	44.71

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
42788: Matched controls
267909

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

102

Kela drug reimbursment

Diabetes insipidus

121.1

318.2

250

D27.98

ICD-10 Finland

Benign tumor of the ovary (ovary), other specified histology

1142.6

317.9

374

N02BE01

ATC

paracetamol; systemic, rectal

1.7

314.1

36886

209520

N05BA04

ATC

oxazepam; oral

1.6

311.2

10851

47388

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

309.2

2155

5403

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

308.4

5703

21009

8305

FHL

Supravaginal amputation or resection

6.3

307.7

756

767

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

139.7

307.7

266

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

+∞

307.7

4370

F50.3

ICD-10 Finland

Atypical bulimia nervosa

53.2

307.7

711

N06AB03

ATC

fluoxetine; oral

2.0

307.7

5662

19156

LCA06

NOMESCO Finland

Biopsy of endometrium

2.6

307.7

7480

19954

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

7.3

307.7

1178

1041

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

3.9

307.7

1353

2240

8302

FHL

Tumor removal (e.g., enucleation) or polyp removal

38.1

307.7

392

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

307.7

5823

19655

E22.1

ICD-10 Finland

Hyperprolactinaemia

138.4

307.7

1245

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.2

307.7

16759

61667

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

298.7

307.7

565

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

1130.7

307.7

1194

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

1373.0

307.7

1526

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

307.7

596

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

83.7

307.7

2352

186

F50.8

ICD-10 Finland

Other eating disorders

52.1

307.7

656

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

263.9

307.7

582

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

307.7

8330

33731

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.0

307.7

540

382

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

39.0

307.7

419

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

16.4

307.7

379

146

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

109.9

307.7

12749

1031

2200A

ICD-9 Finland

Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]

+∞

307.7

818

8308

FHL

Hysterectomy and bilateral adnexal removal

8.3

307.7

837

639

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.9

307.7

2405

5309

22099

ICD-8 Finland

Benign neoplasm of ovary, Other and unspecified

+∞

307.7

1030

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.4

307.7

3779

10487

F50.1

ICD-10 Finland

Atypical anorexia nervosa

141.2

307.7

927

P19

ICPC

Drug abuse

8.3

307.7

756

578

P86

ICPC

Anorexia nervosa/bulimia

16.5

307.7

397

152

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

225.8

307.7

4861

152

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

45.9

307.7

291

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.2

307.7

1666

2565

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

13881

60720

D27.92

ICD-10 Finland

Benign granulosa cell tumor in ovary (ovary)

304.2

307.7

434

B18.2

ICD-10 Finland

Chronic viral hepatitis C

9.2

307.7

909

630

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.8

307.7

6154

15044

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.2

307.7

5624

17145

E23.2

ICD-10 Finland

Diabetes insipidus

90.2

307.7

272

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

374.5

307.7

474

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.2

307.7

3625

10747

F50.0

ICD-10 Finland

Anorexia nervosa

238.6

307.7

1222

C56

ICD-10 Finland

Malignant neoplasm of ovary

204.3

307.7

420

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

240.7

307.7

569

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.7

307.7

2704

6503

E23.05

ICD-10 Finland

Lack of TSH

61.7

307.7

352

F50.9

ICD-10 Finland

Eating disorder, unspecified

68.3

307.7

1819

174

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

18.1

307.7

463

162

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

6.7

307.7

3004

2998

Z72.2

ICD-10 Finland

Drug use

10.3

307.7

482

295

N04BC06

ATC

cabergoline; oral

25.9

307.7

592

145

21899

ICD-8 Finland

Uterine fibroma

+∞

307.7

3461

H01AC01

ATC

somatropin; parenteral

33.2

307.7

410

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

73.1

307.7

802

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

4.5

307.7

1769

2540

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

60.0

307.7

7440

936

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

154.9

307.7

465

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

8.2

307.7

779

607

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

307.7

689

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

200.6

307.7

318

H02AB09

ATC

hydrocortisone; systemic

5.0

307.7

1576

2027

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.0

307.7

22807

98244

LCD00

NOMESCO Finland

Hysterectomy

12.2

307.7

3929

2195

N05AH04

ATC

quetiapine; oral

1.7

307.7

7752

30375

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

7.5

307.7

1628

1412

101

Kela drug reimbursment

Anterior pituitary hypofunction

123.2

307.7

1037

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.6

307.7

3474

8908

LCD10

NOMESCO Finland

Vaginal hysterectomy

4.2

307.7

1982

3053

LCB14

NOMESCO Finland

Laparoscopic myolysis

32.3

307.7

1024

203

B02AA02

ATC

tranexamic acid; systemic

2.4

307.7

8682

25491

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

19.3

307.7

391

128

F50.2

ICD-10 Finland

Bulimia nervosa

75.2

307.7

1032

LCB10

NOMESCO Finland

Myomectomy

84.0

307.7

491

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

44.1

307.7

1145

167

D25

ICD-10 Finland

Leiomyoma of uterus

8.2

307.7

937

728

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

96.6

307.7

276

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

8.0

307.7

1991

1631

128

Kela drug reimbursment

Cancers of female genital organs

5.5

307.7

997

1163

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

5.7

307.7

1697

1923

JAL30

NOMESCO Finland

Omentectomy

8.9

307.7

732

524

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

3.6

307.7

1394

2499

LCB11

NOMESCO Finland

Laparoscopic myomectomy

132.6

307.7

357

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

30.3

307.7

1217

259

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

5.1

307.7

1424

1792

G03XB02

ATC

ulipristal; oral

104.4

307.7

380

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

7.1

307.7

718

638

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

37.1

298.8

271

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

325.8

298.5

362

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.9

294.5

1604

3518

A02BC02

ATC

pantoprazole; systemic

1.5

293.1

26398

139797

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

286.0

19105

95277

LBE00

NOMESCO Finland

Salpingectomy

8.8

285.7

457

327

N06AX16

ATC

venlafaxine; oral

1.7

285.4

6466

25223

B01AB05

ATC

enoxaparin; parenteral

1.5

283.1

11276

50552

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

277.6

9609

41699

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

34.2

276.4

255

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

4.9

272.6

718

922

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

270.7

1692

4004

N06AX11

ATC

mirtazapine; oral

1.5

269.6

13690

64455

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

264.9

14292

68050

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

17.3

263.6

297

108

N05CF01

ATC

zopiclone; oral

1.5

262.6

11803

54128

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

100.2

259.9

207

N02AX02

ATC

tramadol; systemic, rectal

1.5

259.4

15392

74573

N05BA01

ATC

diazepam; systemic, rectal

1.8

258.2

4960

18408

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

21.6

257.4

268

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

11.0

253.6

354

203

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.3

249.1

343

192

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

19.1

243.1

264

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

2.5

241.0

1820

4736

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

238.7

5865

23282

N05AH03

ATC

olanzapine; systemic

2.1

238.4

2649

8147

N06AB04

ATC

citalopram; systemic

1.6

238.1

8369

36256

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

237.8

12477

58779

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

2.2

235.9

2291

6673

N03AX16

ATC

[U] pregabalin

1.5

235.6

8593

37521

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

2.1

234.3

2572

7872

H03AA01

ATC

levothyroxine sodium; systemic

1.5

232.6

9936

44871

8204

FHL

Salpingo-oophorectomy

5.9

231.9

510

546

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

114.4

230.7

182

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

228.1

1849

4973

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

222.7

15077

74256

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.6

221.7

878

1569

WX402

NOMESCO Finland

General anaesthesia

1.5

219.0

8037

35063

E23.03

ICD-10 Finland

Lack of ACTH

813.6

218.0

258

8113

FHL

Fractional scraping

2.1

215.6

2268

6819

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.2

215.2

1017

2044

N03AE01

ATC

clonazepam; systemic

2.2

214.4

2203

6561

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

1542.2

214.1

251

W78

ICPC

Pregnancy

0.5

213.8

3006

32736

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

54.2

212.8

181

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

12.5

211.9

276

139

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

211.1

3016

10152

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

211.0

3912

14312

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

8.0

210.3

359

282

LCC10

NOMESCO Finland

Supravaginal hysterectomy

12.1

209.7

278

145

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

208.9

15174

75419

IFC01, ,

SPAT

75.4

205.5

168

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

11.2

205.5

284

160

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

202.9

9542

43735

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

201.6

9962

46093

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

198.3

2356

27041

N80.0

ICD-10 Finland

Endometriosis of uterus

2.8

195.7

1124

2535

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.8

194.6

3229

11404

8307

FHL

Hysterectomy and unilateral removal of adhesions

6.9

192.2

370

340

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.1

191.5

918

1861

N80.1

ICD-10 Finland

Endometriosis of ovary

2.5

189.6

1397

3587

C07AB07

ATC

bisoprolol; oral

1.4

186.7

14982

75311

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

186.7

4257

16485

N05AA02

ATC

levomepromazine; systemic

2.4

185.7

1441

3792

XLA10, ,

NOMESCO Finland

2.1

184.9

2171

6803

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

7.0

183.9

349

315

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

183.0

4246

16515

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

30.2

182.4

173

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

181.9

10417

49374

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

12.0

181.6

241

126

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

1295.7

180.5

212

N06AX21

ATC

duloxetine; oral

1.6

179.6

4752

19114

N05CD07

ATC

temazepam; oral

1.7

179.5

3639

13633

C08CA01

ATC

amlodipine; oral

1.4

177.6

11062

53178

JAL00

NOMESCO Finland

Biopsy of peritoneum

7.8

177.2

310

252

Z3231

NOMESCO Finland

Registered nurse

1.4

176.8

9677

45451

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

176.2

2716

9358

N06AB06

ATC

sertraline; oral

1.6

176.0

4786

19375

P01AB01

ATC

metronidazole; oral, rectal

1.4

175.6

16164

82804

N05AX12

ATC

aripiprazole; systemic

2.2

175.6

1812

5397

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

10.5

175.0

251

151

AA1AD

NOMESCO Finland

CT of head and brain

1.5

174.5

8336

38151

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

2.0

174.1

2289

7471

B01AB10

ATC

tinzaparin; parenteral

1.7

170.0

3415

12752

ULC02

NOMESCO Finland

Hysteroscopy

2.0

169.7

2253

7376

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

56.1

168.9

143

P18

ICPC

Medication abuse

5.9

167.9

369

395

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

18.2

167.4

185

SPAT1379

SPAT

Health check-up of pregnant person

0.5

165.5

2024

23133

A02BC05

ATC

esomeprazole; systemic

1.4

165.4

14976

76314

J02AC01

ATC

fluconazole; systemic

1.3

165.2

17763

92883

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

165.0

1475

4136

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

164.8

5445

23050

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

7.1

163.3

307

274

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

163.0

15769

81113

JAH01

NOMESCO Finland

Laparoscopy

2.1

162.2

1885

5878

S18

ICPC

Laceration/cut

1.3

161.1

15487

79546

UJF32

NOMESCO Finland

Coloscopy

1.4

161.0

8460

39331

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

56.9

160.9

136

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

160.4

691

1307

N05BA12

ATC

alprazolam; oral

1.7

159.0

3667

14210

301

Kela drug reimbursment

Growth hormone

21.0

158.9

167

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

158.4

5685

49977

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

590.7

157.9

188

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

1112.7

155.5

183

N05CF02

ATC

zolpidem; oral

1.5

155.4

6644

29667

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

155.4

3010

11110

J01AA02

ATC

doxycycline; systemic

1.4

155.3

30028

170245

N03AX09

ATC

lamotrigine; oral

1.9

154.5

2119

7012

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

154.2

8199

38158

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

153.9

3700

14490

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

24.6

153.0

153

ZY010

NOMESCO Finland

Hospital outpatient

1.9

152.8

2178

7302

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

152.6

2085

6890

E23.06

ICD-10 Finland

Empty sella

380.8

151.0

182

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

150.8

1963

6377

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

5.7

149.9

342

381

SPAT1380

SPAT

Postpartum check-up

0.5

149.7

1614

19224

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

149.4

1462

4257

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

149.1

5277

22640

C07AA05

ATC

propranolol; systemic

1.4

146.9

8242

38681

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

28.6

146.7

141

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

146.1

1423

4135

Z2221

NOMESCO Finland

Medical doctor

1.4

145.4

10295

50235

2395A

ICD-9 Finland

Neoplasm of unspecified nature, Other genito-urinary organs

+∞

144.8

168

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

143.9

167

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.0

142.8

727

1528

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

15.2

142.3

169

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

57.5

141.0

119

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

43.3

140.7

124

G02CB01

ATC

bromocriptine; systemic

2.7

140.7

857

1995

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

140.5

2812

28188

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

140.3

2500

8994

N06AB10

ATC

escitalopram; oral

1.4

138.1

8637

41232

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.6

136.4

936

2318

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

2.8

136.2

789

1787

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

4.4

134.7

406

588

N03AX12

ATC

[U] gabapentin; oral

1.5

134.2

5616

24900

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

133.7

6855

56819

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

133.6

155

SPAT1153

SPAT

Removal of sutures

1.4

132.5

10088

49661

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

131.5

12452

63308

F50

ICD-10 Finland

Eating disorders

21.9

131.2

136

N05AF03

ATC

chlorprothixene; systemic

2.4

131.0

990

2570

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

7.6

130.9

232

192

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

130.9

3516

14131

W11

ICPC

Contraception oral

0.6

130.7

1931

20989

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

130.1

151

JN4BD

NOMESCO Finland

Extensive body CT

1.7

129.5

2844

10851

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

128.7

4873

21156

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

128.4

1263

3684

D27

ICD-10 Finland

Benign neoplasm of ovary

15.2

126.4

150

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

125.6

3228

30602

M79.6

ICD-10 Finland

Pain in limb

1.3

124.8

15843

83686

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.6

124.6

2650

26241

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

64.6

123.8

103

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

30.6

123.8

117

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

123.7

3176

12614

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

123.3

1288

3849

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

192.1

122.4

152

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

908.7

121.1

143

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

119.9

3330

31076

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

119.6

4942

21815

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.5

119.5

1455

16752

N03AG01

ATC

valproic acid; systemic, rectal

1.8

119.2

2135

7683

MAX99

NOMESCO Finland

Assistance to normal delivery

0.6

119.1

1696

18653

N06AA09

ATC

amitriptyline; systemic

1.6

118.9

3184

12773

F60.2

ICD-10 Finland

Dissocial personality disorder

9.4

118.9

182

122

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.7

117.8

3539

32498

Z3226

NOMESCO Finland

Physiotherapist

1.4

117.7

6157

28401

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

117.7

8826

43211

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

117.5

738

1746

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

116.9

1152

3362

N05BE01

ATC

buspirone; oral

2.3

116.8

1052

2956

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

116.8

560

1135

SPAT1308

SPAT

Sexual health counselling

0.6

116.6

3089

29135

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.7

116.3

439

758

Z2446

NOMESCO Finland

Social worker

1.7

115.9

2365

8835

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

115.5

4166

17874

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

115.3

2888

11392

M01AH05

ATC

etoricoxib; oral

1.3

115.2

23476

131029

R2110

NOMESCO Finland

Giving the first information

1.7

114.8

2676

10362

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

114.6

133

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

113.9

802

2011

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

179.1

113.9

142

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

112.8

1597

5332

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

5.5

112.5

264

303

N02AA05

ATC

oxycodone; systemic

1.5

112.1

4764

21123

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

112.1

16000

85413

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

111.8

2312

8668

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

111.7

2223

8244

N05AX08

ATC

risperidone; systemic

1.7

111.6

2638

10250

N06AB05

ATC

paroxetine; oral

1.7

111.6

2216

8214

SPAT1272

SPAT

Drug screening

6.3

111.4

231

232

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

4.6

110.9

316

436

ZXE00

NOMESCO Finland

One hour or less

1.3

110.5

14182

74672

M03BX02

ATC

tizanidine; oral

1.3

109.9

24201

135947

G02CB03

ATC

cabergoline; oral

5.1

109.7

279

347

G47.3

ICD-10 Finland

Sleep apnoea

1.4

109.0

6477

30498

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

10.0

108.5

160

101

LBE10

NOMESCO Finland

Bilateral salpingectomy

13.9

107.8

133

A04AA01

ATC

ondansetron; systemic, rectal

1.6

107.6

2665

10475

A02BC03

ATC

lansoprazole; oral

1.3

106.3

9494

47574

C03CA01

ATC

furosemide; systemic

1.4

106.2

7718

37515

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

106.0

123

N39.3

ICD-10 Finland

Stress incontinence

1.6

105.6

2834

11362

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

5.6

105.6

241

269

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

105.0

2926

11836

M02AA07

ATC

piroxicam; topical

1.3

104.9

11932

61759

ZXC86

NOMESCO Finland

Use of endoscopic device

5.6

104.7

240

269

N06AX12

ATC

bupropion; oral

1.6

104.5

2913

11784

M01AB05

ATC

diclofenac; systemic, rectal

1.3

104.0

24755

139866

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

772.0

103.9

123

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.5

103.2

1270

14604

J01DB01

ATC

cefalexin; oral

1.3

103.2

33086

193757

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

102.9

912

2544

Y28

ICPC

Limited function/disability (Y)

9.1

102.8

160

110

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.8

102.8

606

1386

3009

Kela drug reimbursment

Niraparib

30.4

102.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

102.4

1697

5959

TLC02

NOMESCO Finland

Simple extraction of IUD

1.8

102.2

1860

6720

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

102.1

5218

23915

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

102.1

3119

12888

R42

ICD-10 Finland

Dizziness and giddiness

1.3

101.6

7644

37317

J01DA01

ATC

[U] cefalexin

1.3

101.4

23464

131949

30430

ICD-8 Finland

Drug dependence, Other hypnotics and sedatives or tranquillisers

+∞

99.9

116

Z2445

NOMESCO Finland

Psychologist

1.9

99.9

1552

5340

1510

Kela drug reimbursment

Niraparib

29.8

99.9

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

114.8

99.6

128

M01AC06

ATC

meloxicam; systemic, rectal

1.3

99.5

12600

66002

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

98.7

4339

19331

N81.6

ICD-10 Finland

Rectocele

1.6

98.1

2462

9704

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

98.0

834

2286

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

97.6

1413

4750

6171A

ICD-9 Finland

Endometriosis of ovary

3.2

97.6

444

871

IER01

NOMESCO Finland

Psychoeducation, group

3.7

97.1

359

611

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.6

96.9

1510

16246

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

96.6

6845

33084

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

2.6

96.4

633

1533

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

12.9

96.1

123

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

14.7

95.7

115

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

95.7

810

2215

J01CA08

ATC

pivmecillinam; oral

1.2

95.6

18827

103682

C09CA06

ATC

candesartan; oral

1.3

94.9

7846

38785

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

94.9

13108

69293

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

94.8

110

JN4AD

NOMESCO Finland

Body CT examination

1.6

94.7

2522

10083

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

4.4

94.6

282

405

M01AX05

ATC

glucosamine; oral

1.4

94.3

5583

26211

ZY000

NOMESCO Finland

Hospital inpatient

2.8

93.7

548

1248

A06AD11

ATC

lactulose; oral

1.5

93.5

4053

17998

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

93.0

108

JEA00

NOMESCO Finland

Appendectomy

1.7

92.7

2053

7831

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

92.4

1146

3651

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.9

92.3

315

505

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

92.2

4299

19350

R06.0

ICD-10 Finland

Dyspnoea

1.3

91.4

8562

43039

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

90.9

7116

34873

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

90.8

6269

30145

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

90.6

9511

48530

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

19.2

90.6

R53

ICD-10 Finland

Malaise and fatigue

1.3

90.4

8844

44709

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

89.6

104

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

88.7

1815

6775

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

88.7

5954

28495

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

88.6

2051

7914

M01AH01

ATC

celecoxib; oral

1.4

88.5

5800

27652

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

88.2

4621

21229

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

5.9

88.1

192

204

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

2.1

87.8

973

2973

205

Kela drug reimbursment

Chronic hypertension

1.3

87.8

6394

30982

E29.1

ICD-10 Finland

Testicular hypofunction

3.9

87.3

304

495

LCA10

NOMESCO Finland

Curettage of body of uterus

2.0

87.1

1013

3152

L01XK02

ATC

niraparib; oral

28.9

86.6

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.8

86.3

1383

4803

J01MA02

ATC

ciprofloxacin; systemic

1.3

86.0

12322

65234

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

3.2

85.8

385

749

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

4.8

85.7

230

301

6421

FHL

Appendicectomy

1.7

85.7

1624

5932

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

28.6

85.3

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

85.2

1763

6600

H02AB02

ATC

dexamethasone; systemic

1.5

85.1

3402

14858

N06AA12

ATC

doxepin; systemic

1.8

84.9

1548

5590

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

84.8

4172

18944

UKC02

NOMESCO Finland

Cystoscopy

1.5

84.6

3462

15188

M54.5

ICD-10 Finland

Low back pain

1.2

84.5

13391

71671

LCB20

NOMESCO Finland

Transvaginal myomectomy

25.1

84.4

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

83.5

2925

12432

C10AA05

ATC

atorvastatin; oral

1.3

83.2

11002

57649

M01AE02

ATC

naproxen; oral, rectal

1.2

83.2

22067

124647

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

83.2

918

2800

E66.8

ICD-10 Finland

Other obesity

1.6

83.2

2139

8472

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

83.2

10759

56231

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

83.1

7642

38246

A02BC01

ATC

omeprazole; systemic

1.3

83.0

9090

46543

C08CA13

ATC

lercanidipine; oral

1.4

82.9

3866

17383

J01FF01

ATC

clindamycin; systemic

1.3

82.2

9034

46266

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

2.8

81.8

471

1064

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

81.7

4237

19411

E22.80

ICD-10 Finland

Central precocious puberty

309.9

81.7

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

14.4

81.7

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

3.0

81.5

417

880

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

80.9

989

3135

C10AA01

ATC

simvastatin; oral

1.3

80.8

10416

54375

M01AX17

ATC

nimesulide; oral

1.3

80.7

7234

36057

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

80.0

1926

7503

62530

ICD-8 Finland

Other diseases of uterus, Endometriosis ovarii

3.1

79.9

383

777

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

79.9

1873

7248

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

19.3

79.6

105

Kela drug reimbursment

Adrenal cortical hypofunction

6.8

79.5

153

141

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.2

79.5

366

724

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

79.4

6359

31192

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

79.4

28046

162730

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.1

79.4

168

173

C09CA01

ATC

losartan; oral

1.3

78.7

7107

35449

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.4

78.7

592

1534

62699

ICD-8 Finland

Disorders of menstruation, Other

2.2

78.6

767

2228

WX002

NOMESCO Finland

Sedation and analgesia

1.3

78.4

5830

28285

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

78.4

15337

83781

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

78.1

636

1709

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

78.0

6072

29656

H02AB06

ATC

prednisolone; systemic

1.2

77.9

16530

91039

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

77.5

14892

81171

F34.1

ICD-10 Finland

Dysthymia

1.8

77.5

1344

4782

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

77.2

2115

8504

A02BA02

ATC

ranitidine; systemic

1.3

77.0

5669

27456

1413

FHL

Laparoscopy and other therapeutic procedure

2.1

76.9

871

2684

M25.5

ICD-10 Finland

Pain in joint

1.2

76.8

11880

63250

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

76.7

1876

7336

N06AX05

ATC

trazodone; oral

2.0

76.5

923

2911

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

76.5

3360

14929

C10AA07

ATC

rosuvastatin; oral

1.3

76.3

9066

46808

N06AX26

ATC

vortioxetine; oral

1.5

76.1

2783

11925

L17

ICPC

Foot/toe symptom/complaint

1.3

75.5

9834

51326

X78

ICD-10 Finland

Intentional self-harm by sharp object

3.7

75.3

277

470

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.3

75.1

638

1748

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

14.1

75.0

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

74.9

2861

12370

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

3.1

74.4

354

715

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

74.4

3358

14993

L28

ICPC

Limited function/disability (L)

1.3

74.1

5101

24448

T90

ICPC

Diabetes non-insulin dependent

1.3

73.9

5973

29308

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

73.8

5628

27386

J01EA01

ATC

trimethoprim; systemic

1.3

73.6

10301

54175

G04BD12

ATC

mirabegron; oral

1.5

73.4

3112

13730

X78

ICPC

Fibromyoma uterus

16.5

73.3

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

16.8

73.0

N06AX03

ATC

mianserin; oral

1.7

72.8

1443

5335

W90

ICPC

Uncompl labour/delivery livebirth

0.5

72.8

710

8810

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

72.8

778

2344

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

72.8

1096

3731

J01MA12

ATC

levofloxacin; systemic

1.3

72.6

5116

24600

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

72.4

1165

4050

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

539.1

72.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

72.2

4765

22682

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

72.1

12278

65943

R52.2

ICD-10 Finland

Other chronic pain

1.8

71.9

1207

4251

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

2.3

71.9

613

1682

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

71.7

4003

18548

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

71.5

3949

18263

30488

ICD-8 Finland

Drug dependence, Other

+∞

71.5

L13

ICPC

Hip symptom/complaint

1.3

71.1

5743

28159

N05AB03

ATC

perphenazine; systemic, rectal

1.8

71.0

1092

3743

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

70.9

10094

53146

E23.6

ICD-10 Finland

Other disorders of pituitary gland

25.8

70.9

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

27.0

70.8

J01FA06

ATC

roxithromycin; oral

1.2

70.8

14063

76710

A10BA02

ATC

metformin; oral

1.3

70.7

7417

37657

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

2.8

70.7

406

916

30499

ICD-8 Finland

Drug dependence, Unspecified

+∞

70.6

ZXA10

NOMESCO Finland

Bilateral

1.3

70.5

5744

28196

R4110

NOMESCO Finland

Physiotherapy

1.3

70.5

8839

45859

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.6

70.4

479

1182

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

8.3

70.3

117

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

2.6

69.8

453

1091

G03DC02

ATC

norethisterone; oral

1.4

69.8

3936

18263

E24.8

ICD-10 Finland

Other Cushing syndrome

+∞

69.8

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

69.8

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

520.2

69.6

N05AH02

ATC

clozapine; systemic

2.3

69.5

616

1719

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

12.0

69.5

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.5

69.5

902

10247

N07BB01

ATC

disulfiram; oral

1.8

69.2

1144

4011

62620

ICD-8 Finland

Disorders of menstruation, Excessive

2.6

69.0

439

1047

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

68.9

36882

221736

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

68.9

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

68.9

D39.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ovary

4.4

68.8

202

287

LAE20

NOMESCO Finland

Bilateral oophorectomy

6.4

68.3

139

137

R18

ICD-10 Finland

Ascites

2.5

67.9

495

1264

OAA11, ,

SPAT

0.5

67.7

841

9681

IGV01

NOMESCO Finland

Psychiatric network contact

2.7

67.4

410

955

R60.0

ICD-10 Finland

Localized oedema

1.4

67.3

3542

16237

N05AN01

ATC

lithium; oral

2.0

67.3

828

2630

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.0

67.1

761

2346

SPAT1196

SPAT

Monitoring of normal pregnancy

0.6

67.0

1160

12184

ZXA00

NOMESCO Finland

Right side

1.3

66.8

7850

40378

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.5

66.6

490

1257

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

66.4

2793

12294

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

66.3

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

2.5

66.2

468

1177

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

66.1

4450

21228

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.0

65.7

786

2472

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

65.7

1901

7737

8202

FHL

Oophorectomy

5.5

65.6

153

175

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

65.4

9684

51126

R51.80

ICD-10 Finland

Headache

1.3

65.4

5930

29512

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

65.2

2376

10166

N30.0

ICD-10 Finland

Acute cystitis

1.3

65.1

6352

31914

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

64.9

5905

29398

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

15.1

64.8

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

64.6

3389

15523

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

64.6

6320

31761

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

64.4

1584

6200

R4190

NOMESCO Finland

Nutritional therapy

1.7

64.2

1258

4636

ZXY60

NOMESCO Finland

2-person team, nurses

3.4

64.1

266

492

R06AE07

ATC

cetirizine; oral

1.2

63.9

17303

96916

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

16.0

63.8

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

63.7

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

11.0

63.5

T05

ICPC

Feeding problem of adult

2.8

63.5

372

849

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

18.8

63.3

MA3AE

NOMESCO Finland

Combined first trimester screening

0.6

63.3

898

9951

LAE10

NOMESCO Finland

Unilateral oophorectomy

4.7

63.3

175

236

F50.5

ICD-10 Finland

Vomiting associated with other psychological disturbances

86.8

63.1

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

63.0

13868

76161

8351

FHL

Removal of pelvic floor brackets

4.3

62.9

192

282

R03AC02

ATC

salbutamol; inhalant

1.2

62.9

21141

120670

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

62.9

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

62.7

5762

28708

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

62.6

1534

5998

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

62.1

1658

6619

M01AH02

ATC

rofecoxib; oral

1.4

61.7

3620

16889

G03DB01

ATC

dydrogesterone; oral

1.3

61.5

5388

26668

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

61.5

2852

12779

N05BA02

ATC

chlordiazepoxide; systemic

2.2

61.4

579

1660

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

6.2

61.3

128

130

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

5.2

61.3

152

185

B17.1

ICD-10 Finland

Acute hepatitis C

8.2

61.1

102

E34.35

ICD-10 Finland

Abnormal growth retardation

4.6

60.8

171

234

G04BD08

ATC

solifenacin; oral

1.6

60.8

1735

7036

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

10.2

60.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

60.7

13437

73763

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

4.5

60.7

175

245

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.9

60.5

328

717

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

2.6

60.4

395

956

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.3

60.3

263

503

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

60.3

3083

14053

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

59.9

878

2962

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

0.5

59.9

608

7453

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.7

59.8

2390

21006

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

59.5

867

2919

N06AG02

ATC

moclobemide; oral

1.7

59.4

1263

4760

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

58.4

1579

6323

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.5

58.2

651

7739

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.5

58.2

419

1064

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

58.2

6239

31674

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.7

58.1

215

367

N02BF02

ATC

pregabalin; oral

1.5

58.1

1845

7663

1350

FHL

Hysteroscopy

2.8

57.9

328

735

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

57.9

6747

34593

SPAT1315

SPAT

Periodic health check-up of children and adolescents

0.6

57.8

1499

14337

30650

ICD-8 Finland

Special symptoms not elsewhere classified, Feeding disturbance

+∞

57.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

57.7

2697

12097

HA1AA

NOMESCO Finland

X-ray mammography

1.4

57.7

2723

12236

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

57.5

4317

20897

C03AA03

ATC

hydrochlorothiazide; oral

1.5

57.5

2273

9878

IFC99

NOMESCO Finland

Other biological psychiatric intervention

7.2

57.4

105

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

57.4

945

3309

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.0

57.3

688

2167

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

57.3

3481

16322

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.4

57.3

2530

11231

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

57.2

2768

12490

XCK00

NOMESCO Finland

Perimetry

1.5

57.1

1778

7354

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

5.3

57.1

138

164

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

56.9

3573

16839

SPAT1265

SPAT

Breathalyser

3.0

56.8

294

626

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

56.7

7657

39915

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

56.7

8034

42104

J02AC02

ATC

itraconazole; systemic

1.3

56.7

5889

29769

N06AA06

ATC

trimipramine; systemic

2.0

56.7

714

2288

N05AD01

ATC

haloperidol; systemic

1.9

56.5

790

2624

R11

ICD-10 Finland

Nausea and vomiting

1.4

56.5

2968

13585

C05AA08

ATC

fluocortolone; rectal, topical

1.3

56.5

4088

19682

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

56.5

535

1537

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

56.4

20693

118513

A46

ICD-10 Finland

Erysipelas

1.4

56.4

3663

17353

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

56.0

3751

17853

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.8

55.9

890

3083

L15

ICPC

Knee symptom/complaint

1.2

55.9

7965

41756

JAH00

NOMESCO Finland

Laparotomy

2.0

55.9

707

2269

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.0

55.8

288

612

C07AB02

ATC

metoprolol; systemic

1.3

55.7

5170

25757

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.7

55.6

340

795

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

55.5

2246

9804

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

55.5

3944

18935

104

Kela drug reimbursment

Thyroid insufficiency

1.4

55.5

2377

10490

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

212.2

55.3

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

0.5

55.1

544

6731

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

55.1

4251

20652

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

13.8

54.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

54.9

10896

59070

M02AA10

ATC

ketoprofen; topical

1.3

54.8

4906

24321

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

54.8

14987

83642

L03

ICPC

Low back symptom/complaint

1.2

54.8

9926

53332

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

54.7

1714

7096

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

54.6

3034

14015

SPAT1227

SPAT

Substance abuse rehabilitation

3.4

54.6

227

421

H01CC54

ATC

relugolix, estradiol and norethisterone; systemic

9.0

54.4

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.1

54.4

571

1710

ZXA05

NOMESCO Finland

Left side

1.2

54.2

7208

37486

N06AX22

ATC

agomelatine; oral

1.8

54.1

850

2933

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

54.0

4325

21118

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

54.0

8184

43169

R50.9

ICD-10 Finland

Fever, unspecified

1.3

53.8

4600

22660

S29

ICPC

Skin symptom/complaint other

1.3

53.7

6045

30837

R4140

NOMESCO Finland

Psychotherapy

3.0

53.7

266

552

O81.4

ICD-10 Finland

Vacuum extractor delivery

0.6

53.5

1011

10404

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

53.4

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

5.1

53.3

133

163

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.0

53.3

265

551

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

53.2

7566

39626

PD2DT

NOMESCO Finland

Embolisation of gynekological tumor

74.2

53.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

52.9

3334

15713

X84

ICD-10 Finland

Intentional self-harm by unspecified means

4.5

52.9

153

215

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.1

52.9

585

1788

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

15.5

52.8

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

106.6

52.8

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.6

52.7

202

354

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.1

52.7

589

1807

F93.89

ICD-10 Finland

Other childhood emotional disorders

2.6

52.7

334

796

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

52.6

1517

6164

SFA30

NOMESCO Finland

Three-surface restoration

1.2

52.6

14370

80107

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.7

52.5

1159

4411

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

52.5

4708

23337

OAA12, ,

SPAT

0.5

52.4

517

6399

N02BF01

ATC

gabapentin; oral

1.4

52.4

2482

11155

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

16.4

52.2

Z37.0

ICD-10 Finland

Single live birth

0.7

52.1

2050

18094

SPAT1216

SPAT

Assessment of functional ability

1.3

52.1

4205

20548

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

51.9

3712

17827

D35.30

ICD-10 Finland

Craniopharyngoma

85.3

51.7

6170A

ICD-9 Finland

Endometriosis of uterus

2.7

51.7

309

714

E23.0

ICD-10 Finland

Hypopituitarism

388.2

51.7

N81.5

ICD-10 Finland

Vaginal enterocele

2.1

51.5

554

1675

OAB43, ,

SPAT

0.8

51.5

9262

67128

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

51.4

2640

12033

X77

ICPC

Malignant neopl genital female other

5.2

51.2

125

150

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

196.4

51.1

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

3.8

51.1

178

291

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

51.0

3820

18469

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

9.5

50.8

G02CB04

ATC

quinagolide; oral

14.7

50.8

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

50.7

3108

14582

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

50.6

8889

47549

1410

FHL

Laparoscopy

1.8

50.5

912

3283

R52.9

ICD-10 Finland

Pain, unspecified

1.4

50.5

3156

14851

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.7

50.4

1136

4348

A03FA02

ATC

cisapride; oral, rectal

1.4

50.3

2140

9427

G01AF01

ATC

metronidazole; vaginal

1.3

50.2

3478

16621

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

50.1

3153

14851

D72

ICPC

Viral hepatitis

8.1

50.0

ZXY49

NOMESCO Finland

Other health care provider

3.3

49.9

217

415

P76

ICPC

Depressive disorder

1.4

49.9

2473

11201

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

49.8

1190

4622

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

49.7

925

3360

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.1

49.6

511

1519

T99

ICPC

Endocr/metab/nutrit disease other

2.2

49.5

471

1356

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

49.5

9628

51992

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

49.4

2029

8878

E25.9

ICD-10 Finland

Adrenogenital disorder, unspecified

192.3

49.4

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

49.3

5223

26428

M48.0

ICD-10 Finland

Spinal stenosis

1.4

49.2

2987

13988

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

49.2

5977

30733

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

49.0

1402

5688

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

48.9

840

2980

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

48.8

5202

26337

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

48.6

2344

10563

K85

ICPC

Elevated blood pressure

1.3

48.6

4273

21110

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.0

48.5

564

1756

SPAT1240

SPAT

Therapeutic discussion

1.3

48.5

4058

19914

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

48.4

7147

37533

WZC30

NOMESCO Finland

Teaching

1.3

48.4

4372

21677

D01

ICPC

Abdominal pain/cramps general

1.3

48.3

4248

20986

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

48.3

1150

4463

W12

ICPC

Contraception intrauterine

0.7

48.3

2504

21121

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

48.2

1058

4021

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

48.2

644

2108

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.6

48.1

1230

4858

N06AB08

ATC

fluvoxamine; oral

1.8

48.1

780

2719

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

2.8

47.9

275

622

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

47.8

1783

7657

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.1

47.7

475

1393

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

47.7

2568

11793

E23.08

ICD-10 Finland

Hypopituitarism

185.8

47.7

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

47.7

3095

14644

A28

ICPC

Limited function/disability NOS

1.3

47.7

4145

20446

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

79.0

47.6

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

47.5

5875

30257

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

3.8

47.4

170

284

G01AF05

ATC

econazole; vaginal

1.4

47.3

2924

13731

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

2.6

47.2

299

713

62533

ICD-8 Finland

Other diseases of uterus, Adenomyosis uteri

3.1

47.1

219

437

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

47.0

1609

6788

MAE00

NOMESCO Finland

Outlet vacuum delivery

0.6

47.0

830

8688

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.2

46.8

8372

44810

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

46.7

3347

16068

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

46.7

1724

7386

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

46.4

2473

11338

S10

ICPC

Boil/carbuncle

1.5

46.4

1645

6992

K59.0

ICD-10 Finland

Constipation

1.5

46.3

1576

6640

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.7

46.3

974

3660

62532

ICD-8 Finland

Other diseases of uterus, Endometriosis retro-cervicalis sive retrouterina

2.4

46.3

349

907

J05AB01

ATC

aciclovir; systemic

1.2

46.3

7553

40055

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

4.8

46.2

124

163

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

46.2

4524

22654

P29

ICPC

Psychological sympt/compl other

1.4

46.1

2615

12110

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

46.1

4416

22053

N83.0

ICD-10 Finland

Follicular cyst of ovary

2.0

46.0

547

1718

6173B

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS RETROUTERINA]

2.4

45.9

343

888

IEY01

NOMESCO Finland

Psychoeducation, individual

2.6

45.9

310

764

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

45.6

4303

21444

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

121.2

45.6

ZXD20

NOMESCO Finland

Day surgery

1.3

45.5

4033

19935

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.9

45.5

665

2243

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

45.3

2071

9241

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

4.3

45.3

137

200

LAC00

NOMESCO Finland

Excision of ovarian cyst

4.4

45.3

134

192

8460/3-C56.9

ICD-O-3

Low grade serous carcinoma of ovary

92.5

45.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

45.3

3842

18882

A01

ICPC

Pain general/multiple sites

1.4

45.2

2851

13425

N83.1

ICD-10 Finland

Corpus luteum cyst

2.0

45.2

507

1559

G04BD07

ATC

tolterodine; oral

1.6

45.2

1278

5171

G44.2

ICD-10 Finland

Tension-type headache

1.3

45.2

5042

25649

Z71.8

ICD-10 Finland

Other specified counselling

1.2

45.1

11326

62476

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.7

45.1

856

3127

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

45.1

7840

41824

L08

ICPC

Shoulder symptom/complaint

1.2

45.0

6721

35307

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

5.9

44.8

105

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

337.8

44.8

C09AA02

ATC

enalapril; systemic

1.3

44.8

4525

22740

F11.00

ICD-10 Finland

Intoxication caused by opiates uncomplicated

+∞

44.8

T40.2

ICD-10 Finland

Poisoning: Other opioids

9.9

44.7

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.7

44.6

991

3778

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

44.6

831

3019

OAA10, ,

SPAT

0.5

44.6

530

6189

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

44.5

1971

8744

IBZ15, ,

SPAT

6.9

44.4

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

44.3

2059

9214

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.5

44.2

310

778

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

44.2

2700

12649

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

44.1

1074

4191

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

44.1

1473

6182

P74

ICPC

Anxiety disorder/anxiety state

1.5

44.1

1601

6837

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.3

44.1

388

1082

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

43.9

6036

31422

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

1.9

43.9

637

2144

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

43.8

2493

11548

WX320

NOMESCO Finland

Spinalanesthesy

1.2

43.8

7268

38577

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

43.8

5955

30964

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

43.8

2682

12571

M79.7

ICD-10 Finland

Fibromyalgia

1.5

43.6

1291

5278

C09DA01

ATC

losartan and diuretics; oral

1.4

43.4

2622

12261

R63.0

ICD-10 Finland

Anorexia

3.6

43.4

163

282

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

43.3

5955

30997

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.2

43.3

384

1074

6200A

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Follicular cyst of ovary

3.0

43.3

217

454

F11.09

ICD-10 Finland

Intoxication caused by opiates UNS

325.3

43.1

U02

ICPC

Urinary frequency/urgency

1.3

43.1

4928

25130

D06

ICPC

Abdominal pain localized other

1.3

43.0

2985

14256

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

42.9

17517

100303

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

42.9

3543

17344

R05

ICD-10 Finland

Cough

1.2

42.9

7007

37128

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

4.9

42.8

112

144

P99

ICPC

Psychological disorders other

1.6

42.8

996

3844

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

1.9

42.7

612

2052

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

3.5

42.6

170

307

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

42.6

723

2557

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

42.5

3949

19630

LAD00

NOMESCO Finland

Partial excision of ovary

5.3

42.5

103

123

AA400

NOMESCO Finland

Electroconvulsive therapy

2.6

42.4

281

686

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

42.4

1594

6855

L03AA13

ATC

pegfilgrastim; parenteral

1.5

42.3

1255

5132

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.0

42.3

486

1508

N83.5

ICD-10 Finland

Torsion of ovary, ovarian pedicle and fallopian tube

2.8

42.3

232

512

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

3.7

42.2

154

261

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

42.2

6683

35295

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

42.0

2909

13891

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.1

41.8

458

1396

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.2

41.8

405

1176

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

70.2

41.8

C03DA01

ATC

spironolactone; oral

1.3

41.8

2867

13670

IBZ03

NOMESCO Finland

Addiction psychiatry evaluation

13.6

41.8

N07BC51

ATC

buprenorphine, combinations; sublingual

163.3

41.8

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

0.7

41.6

1893

16322

E87.6

ICD-10 Finland

Hypokalaemia

1.7

41.5

899

3406

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

41.4

2321

10724

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

+∞

41.3

E0000UV, ,

ATC

1.2

41.3

15236

86505

SPAT1260

SPAT

Consultation of another employee

1.2

41.2

5593

29059

W85

ICPC

Gestational diabetes

0.6

41.2

653

7030

R35

ICD-10 Finland

Polyuria

1.5

41.2

1423

6015

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

6.9

41.1

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

41.1

402

1172

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

41.0

702

2488

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

41.0

2317

10719

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.0

41.0

500

1586

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.6

40.9

1070

10235

S06.0

ICD-10 Finland

Concussion

1.3

40.9

3377

16523

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

40.9

6353

33471

O80.8

ICD-10 Finland

Other single spontaneous delivery

0.6

40.6

752

7781

R01AD08

ATC

fluticasone; nasal

1.2

40.6

10180

56047

F99

ICD-10 Finland

Mental disorder, not otherwise specified

1.8

40.5

695

2466

F10.24

ICD-10 Finland

Alcohol depence active use

2.2

40.5

374

1065

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.9

40.5

565

1878

WX704

NOMESCO Finland

Intubation

1.4

40.5

2372

11038

JAL31

NOMESCO Finland

Laparoscopic omentectomy

4.0

40.4

135

214

IBZ99

NOMESCO Finland

Other behavioural observation

23.4

40.3

N04BC05

ATC

pramipexole; oral

1.4

40.2

2049

9317

E66.9

ICD-10 Finland

Obesity, unspecified

1.6

40.2

1152

4675

SPAT1195

SPAT

Antenatal classes

0.5

40.1

429

5172

H25.8

ICD-10 Finland

Other senile cataract

1.4

40.1

2340

10882

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

15.5

40.0

M01AC01

ATC

piroxicam; systemic, rectal

1.3

39.9

3485

17177

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

3.1

39.9

194

399

6173A

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]

2.6

39.8

252

601

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

39.7

771

2835

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

39.6

3847

19224

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

39.5

2345

10932

3017A

ICD-9 Finland

Personality disorders, Antisocial personality disorder

20.2

39.5

LAD01

NOMESCO Finland

Laparoscopic partial excision of ovary

3.5

39.5

153

271

389

Kela drug reimbursment

Olaparib

12.1

39.4

N04AA02

ATC

biperiden; systemic

1.9

39.4

521

1700

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

0.7

39.3

1076

10194

M79.1

ICD-10 Finland

Myalgia

1.2

39.2

4977

25662

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

2.6

39.1

246

585

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.0

39.0

448

1390

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.8

39.0

640

2240

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

0.7

39.0

1244

11433

R02

ICPC

Shortness of breath/dyspnoea

1.3

39.0

3857

19315

RD210, ,

NOMESCO Finland

1.9

39.0

571

1929

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.3

38.9

2624

12474

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

38.9

1200

4952

H53.4

ICD-10 Finland

Visual field defects

1.9

38.8

530

1749

H02AB04

ATC

methylprednisolone; systemic

1.3

38.8

4442

22634

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.4

38.7

299

787

1511

Kela drug reimbursment

Olaparib

11.6

38.7

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

1.3

38.7

2503

11826

XF402

NOMESCO Finland

ECG with work load test

1.4

38.7

2382

11170

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1263

2275

3.55

315.90

2.9

1.7

164.76

175.57

pmol/l

1.99

1219

2156

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1957

1033

12.38

307.65

2.9

1.6

19.51

20.60

nmol/l

2.19

1891

970

(3035637) Corticotropin [Mass/volume] in Plasma

1360

2234

3.90

307.65

1.9

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2899

6887

2.75

307.65

1.8

1.3

9.07

11.16

u/l

10.70

2324

5615

(3021387) Prolactin [Units/volume] in Serum or Plasma

3719

10105

2.43

307.65

2.7

1.3

381.55

292.02

mu/l

15.27

3441

8972

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

755

713

6.73

307.65

1.7

1.2

73.88

72.21

1.74

721

674

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

746

690

6.87

307.65

1.7

1.2

995.45

371.87

mu/l

3.53

712

651

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

33195

181727

1.64

307.65

5.0

4.2

14.62

14.58

pmol/l

2.57

30663

167703

(3023103) Potassium [Moles/volume] in Serum or Plasma

38855

220891

2.10

307.65

16.6

12.9

3.92

3.93

mmol/l

6.33

37992

214492

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

21170

104581

1.53

307.65

6.0

5.6

10.12

10.55

umol/l

5.07

19960

98607

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6402

19510

2.24

307.65

3.0

1.9

362.51

378.95

nmol/l

6.94

5937

17911

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30573

160773

1.67

307.65

7.7

6.9

77.14

76.60

u/l

1.30

28812

151744

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

5241

12729

2.80

307.65

4.5

2.3

63.19

40.10

u/ml

2.83

5095

12248

(43055514) Macroprolactin [Presence] in Serum or Plasma

603

498

7.68

307.65

1.6

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

2718

5274

3.38

307.65

1.5

1.4

154.20

91.95

pmol/l

6.30

2656

5129

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20540

98395

1.59

307.65

6.7

6.0

1.22

mmol/l

0.47

17419

83780

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18763

88422

1.59

307.65

6.1

5.4

1.22

mmol/l

1.77

17145

80995

(3024561) Albumin [Mass/volume] in Serum or Plasma

17948

84872

1.56

307.65

4.6

4.5

36.06

36.11

g/l

0.48

16662

78708

(4281824) Cell count and differential, peritoneal fluid

1155

1899

3.89

307.65

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

845

413

13.05

307.65

3.2

1.7

1.12

1.43

ug/l

1.60

789

397

(40768804) Tissue Pathology biopsy report

18523

88892

1.54

307.65

2.2

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

420

206

12.88

307.65

1.9

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

38783

220270

2.09

307.65

16.5

12.8

139.61

139.63

mmol/l

0.42

37987

214378

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

36840

209781

1.72

299.00

5.9

4.9

1.99

2.05

mu/l

0.21

34270

196020

(3015377) Calcium [Moles/volume] in Serum or Plasma

14589

68976

1.49

285.66

3.3

3.2

2.36

mmol/l

1.54

12818

61353

(3013826) Glucose [Moles/volume] in Serum or Plasma

22816

118064

1.45

278.45

4.8

4.2

6.49

6.50

mmol/l

0.25

21430

108287

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

35781

203096

1.63

276.95

13.4

10.7

85.04

86.24

ml/min/173m2

20.17

29974

165250

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2766

8262

2.17

268.87

4.5

1.8

10.19

10.58

nmol/l

1.47

2537

7435

(3044640) Blood type and Crossmatch panel - Blood

13908

65857

1.48

265.09

2.4

2.2

—

(3018418) pH of Serum or Plasma

12543

58663

1.48

251.07

4.1

3.7

7.40

2.59

2457

10943

(3013707) Erythrocyte sedimentation rate by Westergren method

29629

162594

1.46

250.16

4.2

3.9

11.45

11.31

mm/h

1.05

27561

151698

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

423

330

8.10

249.03

3.2

1.4

94.62

114.24

ng/l

0.64

240

177

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

36179

207128

1.61

248.87

4.6

3.9

5.81

5.74

mmol/l

16.39

33182

191917

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33830

190941

1.52

244.75

5.6

4.9

38.93

38.57

mmol/mol

10.13

31261

178659

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1566

3758

2.67

243.70

2.7

1.5

38.46

43.66

nmol/l

7.30

1508

3691

(3022217) INR in Platelet poor plasma by Coagulation assay

16817

83538

1.43

243.21

12.0

11.3

1.15

1.18

inr

2.23

5202

25257

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19819

101671

1.41

237.20

2.6

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16179

80194

1.42

233.96

2.0

1.9

99.48

98.18

pmol/l

2.32

8130

40956

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18438

93736

1.41

229.59

2.5

2.3

4994.68

76.65

nmol/l

0.50

16673

85931

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13363

64257

1.44

225.98

2.7

2.4

58.08

59.99

u/l

0.61

12244

59418

(3028707) Methadone [Presence] in Urine by Screen method

1759

4651

2.43

225.00

7.1

1.9

—

(3044889) 12 lead EKG panel

26216

141893

1.40

224.14

3.6

3.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

39566

233113

1.83

223.72

16.8

13.1

70.04

70.57

umol/l

3.39

39554

233014

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7086

29917

1.58

223.67

3.6

3.4

0.82

mmol/l

1.06

6617

27961

(3031040) Bacteria [#/volume] in Urine by Automated count

26865

146385

1.40

217.07

4.9

4.2

1279.41

1971.02

e6/l

1.77

319

1752

(3013650) Neutrophils [#/volume] in Blood by Automated count

23601

125959

1.39

214.29

10.0

8.5

3.99

e9/l

0.02

20639

110587

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4529

17286

1.72

211.04

2.4

2.3

0.22

g/l

1.09

4223

16132

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1352

3250

2.66

209.36

2.4

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10562

49199

1.46

207.52

2.3

2.1

—

(3013512) EKG study

11134

52417

1.45

206.74

3.7

3.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5721

23433

1.61

202.92

5.5

5.6

1.06

1.05

mmol/l

0.43

5311

21821

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

687

1130

3.85

194.25

1.9

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

39645

234932

1.77

193.58

11.3

9.2

25.95

24.92

u/l

6.75

38364

227414

(3023323) Follitropin [Units/volume] in Serum or Plasma

4129

15845

1.70

187.28

1.5

1.3

24.08

27.92

iu/l

10.88

3508

13729

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14110

70552

1.38

179.79

3.5

3.1

33.44

31.68

u/l

0.79

13381

67064

(40760892) CBC W Ordered Manual Differential panel - Blood

19496

102740

1.35

176.27

6.6

6.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

38018

223647

1.58

175.51

14.7

11.9

21.10

20.88

mg/l

0.62

30514

173171

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11766

57348

1.39

173.41

2.3

2.0

192.51

180.55

u/l

0.30

11050

53800

(3033658) Prothrombin time (PT) actual/Normal

10612

50896

1.41

171.44

4.0

3.7

95.65

94.24

7.12

10312

49483

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10731

51722

1.40

167.75

2.4

2.2

3.00

2.83

mg/l

9.27

9158

44477

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

257

173

9.35

167.28

1.2

—

(3007463) Buprenorphine [Presence] in Urine

157

29.89

165.12

9.6

2.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13922

70234

1.36

163.58

3.5

3.1

30.08

59.06

ng/l

2.37

8451

40102

(3037467) Urinalysis macro (dipstick) panel - Urine

27360

152506

1.34

163.37

4.7

4.2

—

(3013115) Eosinophils [#/volume] in Blood

21090

113249

1.33

162.25

6.5

6.0

0.18

0.19

e9/l

1.95

18578

100550

(3006315) Basophils [#/volume] in Blood

20455

109438

1.33

160.83

6.2

5.8

0.04

e9/l

0.83

17719

95795

(3001604) Monocytes [#/volume] in Blood

20417

109222

1.33

160.55

6.2

5.8

0.55

e9/l

0.99

17727

95741

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1571

4581

2.19

160.16

1.6

1.4

0.34

0.46

nmol/l

5.48

1192

3652

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4320

17469

1.61

158.50

3.2

4.0

18.05

23.63

ug/l

0.63

3259

13634

(3019309) Folate [Moles/volume] in Red Blood Cells

7417

33743

1.46

158.02

1.8

1.7

1181.62

1183.88

nmol/l

0.07

5593

25883

(3023368) Bacteria identified in Blood by Culture

9878

47394

1.40

156.57

4.5

3.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

530

845

3.96

156.07

2.0

1.5

2357701.72

1951720.17

iu/ml

0.23

(3019198) Lymphocytes [#/volume] in Blood

20964

113017

1.32

152.96

6.2

5.8

1.98

1.96

e9/l

0.53

18624

101216

(3009508) Creatinine [Moles/volume] in Urine

11582

57264

1.37

152.04

4.1

3.1

7.02

7.57

mmol/l

1.47

9708

49382

(3002256) Pathology report gross observation

6070

26749

1.49

151.15

1.3

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

19297

103021

1.31

149.68

6.6

6.2

8.19

8.23

1.31

18025

96959

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

36789

216187

1.47

149.41

4.8

4.3

2.86

mmol/l

0.93

33915

202473

(3021960) Folate [Moles/volume] in Serum or Plasma

9175

43797

1.40

148.51

1.6

1.5

20.77

20.99

nmol/l

0.69

7848

38008

(3006504) Eosinophils/100 leukocytes in Blood

19188

102478

1.31

147.64

6.3

5.9

2.78

2.82

1.39

17887

96259

(3022096) Basophils/100 leukocytes in Blood

18589

99026

1.31

144.53

6.4

6.0

0.69

0.68

0.54

17251

92608

(3036180) Methadone [Presence] in Urine

593

1093

3.43

143.08

3.4

1.9

—

(3002030) Lymphocytes/100 leukocytes in Blood

19814

106671

1.30

141.31

6.4

6.0

29.13

29.19

0.32

18557

100662

(3042517) Benzodiazepines panel - Urine

261

229

7.17

140.76

4.7

1.7

—

(3011288) Drugs identified in Urine by Screen method

2220

7729

1.84

138.48

8.9

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1869

20815

0.54

138.34

1.4

1.5

—

(3021589) Normoblasts [#/volume] in Blood

18169

96924

1.30

137.13

10.1

8.6

0.00

e9/l

0.61

14943

79486

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

36254

213168

1.42

136.27

4.4

3.9

4.82

4.80

mmol/l

4.98

33606

200596

(3018010) Neutrophils/100 leukocytes in Blood

19504

105153

1.30

135.20

6.2

5.8

56.50

56.46

0.21

18256

99145

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3912

16069

1.58

133.05

3.3

4.45

4.53

pmol/l

5.28

3513

14358

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9557

46646

1.36

132.55

2.8

1076.30

1199.67

ng/l

1.76

7927

39142

(40761511) CBC panel - Blood by Automated count

39205

234397

1.56

131.69

14.2

11.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

35993

211651

1.41

131.17

4.4

3.9

1.53

mmol/l

0.34

33166

198576

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

34816

203688

1.38

129.49

3.9

3.5

1.32

1.24

mmol/l

70.15

31805

189975

(3026008) Bacteria identified in Urine by Culture

13196

68112

1.31

123.08

3.2

2.9

—

(3026782) Osmolality of Urine

8080

38784

1.38

122.90

3.0

2.7

511.68

524.58

mosm/kgh2o

4.58

6923

33014

(3030467) Casts [#/volume] in Urine by Automated count

10876

54660

1.33

122.51

3.1

2.9

0.37

0.38

e6/l

0.34

8190

40688

(3022948) Iron [Moles/volume] in Serum or Plasma

6596

30670

1.41

120.87

2.4

2.3

13.41

13.54

umol/l

0.63

6110

28623

(3002582) Erythrocytes [#/volume] in Urine

11719

59694

1.32

119.45

3.3

3.0

96.40

65.62

e6/l

1.13

8889

44696

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4330

18609

1.51

119.37

3.4

3.0

—

(3018095) Leukocytes [#/volume] in Urine

14005

73095

1.30

119.26

3.8

3.4

94.38

95.77

e6/l

0.06

9658

48906

(4035726) Immunohistochemistry procedure

3989

16873

1.53

118.38

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

26524

150122

1.28

117.22

3.5

2.8

43.15

40.34

u/l

5.52

24846

141769

(36304419) Bacteria [Presence] in Urine

10712

54193

1.32

113.41

3.1

2.9

—

(3008295) Osmolality of Serum or Plasma

727

1752

2.63

111.73

2.2

1.4

282.75

278.71

mosm/kgh2o

4.57

602

1338

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19633

107711

1.26

108.26

3.2

2.8

92.80

91.53

ug/l

0.34

18250

101104

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7474

36142

1.36

106.38

2.7

2.8

2.45

2.44

mmol/l

2.47

6527

31455

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5986

27934

1.40

105.95

2.4

2.3

2.43

2.42

g/l

1.45

5469

25818

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5551

25628

1.41

104.38

2.5

2.4

22.24

22.78

1.88

4762

22010

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1431

4731

1.92

103.95

1.5

1.3

22.74

26.83

u/l

4.87

1207

3858

(3009261) Glucose [Presence] in Urine by Test strip

20112

111071

1.25

102.37

4.0

3.5

0.00

estimate

0.04

3996

20621

(3021601) Nitrite [Presence] in Urine by Test strip

19942

110046

1.25

102.09

5.3

4.7

0.00

estimate

0.02

4029

20883

(40758558) Short blood count panel - Blood

10685

54719

1.30

101.06

7.5

6.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9611

48609

1.31

99.47

1.8

1.04

1.08

mg/l

0.55

7193

36502

(3019225) pH of Specimen

4160

18371

1.46

99.12

4.0

3.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8430

41899

1.32

98.77

1.7

1.6

29844581.99

37643168.16

pmol/l

0.60

6993

35295

(3050129) First trimester maternal screen panel - Serum or Plasma

1230

13928

0.54

94.56

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3380

14487

1.50

93.11

3.6

84.29

81.74

ng/l

0.66

2888

12658

(3003396) Base excess in Arterial blood by calculation

4173

18706

1.44

91.47

7.0

6.9

0.99

1.10

mmol/l

0.99

3367

14782

(3015736) pH of Urine

16389

89200

1.24

90.92

3.8

3.2

5.90

5.94

0.61

1255

8080

(3020682) Albumin/Creatinine [Ratio] in Urine

10185

52434

1.28

90.51

3.8

9.53

9.34

mg/mmol

0.09

6016

31999

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4160

18690

1.44

89.99

7.0

6.9

5.14

5.08

kpa

4.22

3974

17809

(3027801) Oxygen [Partial pressure] in Arterial blood

4158

18683

1.44

89.89

7.0

6.9

13.06

12.86

kpa

1.32

3967

17804

(3000850) Epithelial cells [#/volume] in Urine

8230

41295

1.31

88.62

2.7

2.5

7.42

7.37

e6/l

0.06

7328

36693

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10327

53465

1.28

87.09

1.7

1.6

1.43

1.34

mmol/l

19.07

8697

45875

(3012516) Albumin [Mass/volume] in Urine

9735

50043

1.28

86.86

3.2

468.76

449.71

mg/l

0.12

5774

30581

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4925

22939

1.39

86.60

4.4

4.0

32.57

32.71

0.40

3473

16384

(3035350) Ketones [Presence] in Urine by Test strip

19752

110047

1.23

86.56

4.0

3.5

0.00

estimate

0.29

4229

21846

(1001926) Buprenorphine [Presence] in Urine by Screen method

2234

8881

1.61

85.66

6.4

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4180

35328

0.71

85.63

1.7

—

(3042936) Bacteria identified in Isolate by Culture

5610

26737

1.36

85.54

2.0

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

444

945

2.96

85.51

2.1

1.4

4.10

11.15

nmol/l

0.58

386

759

(3009542) Hematocrit [Volume Fraction] of Blood

41075

250629

1.65

84.85

22.9

17.5

39.63

40.05

9.52

39098

236605

(3007461) Platelets [#/volume] in Blood

41105

250909

1.65

83.77

22.9

17.5

266.04

261.35

e9/l

39.30

40281

244921

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6101

29590

1.34

82.70

1.9

1.8

—

(40768797) Stomach Pathology biopsy report

5896

28458

1.34

82.53

1.2

—

(3035941) MCH [Entitic mass]

41115

251108

1.64

81.16

22.8

17.4

30.00

30.11

31.08

40673

248060

(3024731) MCV [Entitic volume]

41117

251134

1.64

80.93

22.8

17.4

90.43

90.48

1.37

40674

248076

(3026361) Erythrocytes [#/volume] in Blood

41119

251158

1.64

80.75

22.9

17.5

4.45

4.47

e12/l

11.67

40196

244618

(3010813) Leukocytes [#/volume] in Blood

41122

251191

1.64

80.53

23.0

17.5

6.69

6.66

e9/l

1.20

40194

244593

(3000963) Hemoglobin [Mass/volume] in Blood

41122

251250

1.64

79.29

23.1

17.6

132.75

133.95

g/l

64.82

40690

248241

(3014111) Lactate [Moles/volume] in Serum or Plasma

3395

15039

1.45

78.62

6.9

6.8

1.28

1.32

mmol/l

1.58

3309

14681

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

880

10421

0.52

78.07

1.4

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5634

27289

1.34

76.47

2.0

1.6

1.43

1.36

13.07

4989

24426

(3027945) Reticulocytes/100 erythrocytes in Blood

4098

18949

1.39

74.46

2.7

2.6

1.77

1.76

0.39

3579

16801

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

774

2326

2.10

72.93

1.3

1.2

33.15

26.95

nmol/l

0.40

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2633

11255

1.50

72.79

7.2

7.3

24.94

24.80

mmol/l

1.22

2614

11160

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3482

15732

1.42

72.16

3.9

3.5

1.23

mmol/l

0.16

3033

13719

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6228

30839

1.31

71.97

2.8

2.7

4.26

4.27

e6/l

0.02

3239

16059

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1078

11709

0.57

70.82

1.4

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

33218

197127

1.25

69.98

18.0

14.1

14.88

14.89

0.05

32717

193647

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6630

33237

1.29

69.63

2.7

2.5

1.31

1.27

e6/l

0.10

3629

18327

(3011985) Renin [Units/volume] in Plasma

841

2656

2.00

69.47

2.0

1.5

62.45

58.93

mu/l

0.18

769

2374

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

809

9469

0.53

68.91

1.7

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10725

57039

1.24

68.25

1.3

1.37

1.64

u/ml

1.53

2874

15806

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4102

19230

1.37

68.21

2.5

2.4

35.06

41.14

u/l

1.24

3524

16446

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1143

4050

1.79

66.74

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4866

23497

1.33

66.65

2.7

6.59

7.37

umol/l

1.95

4077

19957

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1015

11001

0.57

66.04

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1008

10941

0.57

65.93

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1015

10995

0.57

65.90

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1014

10972

0.57

65.56

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3376

15422

1.40

65.42

7.7

120.58

120.61

g/l

0.03

3285

14987

(3007164) IgA [Mass/volume] in Serum or Plasma

9185

48278

1.24

64.39

1.5

1.4

2.17

2.23

g/l

2.23

5457

29631

(3000991) Gas panel - Venous blood

3243

14757

1.41

64.21

8.5

8.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

533

1465

2.29

62.33

3.4

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4088

19417

1.35

62.20

3.9

4.0

237.39

239.77

u/l

0.46

3830

18350

(3016502) Oxygen saturation in Arterial blood

3564

16569

1.38

62.07

7.5

7.3

95.93

95.92

0.04

3442

15892

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3518

16336

1.38

61.69

4.7

4.0

5.88

5.83

kpa

2.17

3420

15846

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5603

27892

1.30

61.26

2.2

29.51

29.45

0.28

5438

27017

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4808

23456

1.32

60.92

6.8

6.1

—

(3002032) Base excess in Venous blood by calculation

3500

16285

1.38

60.57

4.8

4.0

1.94

1.90

mmol/l

0.22

3013

13854

(3024354) Oxygen [Partial pressure] in Venous blood

2984

13518

1.41

60.46

4.1

3.5

4.63

4.64

kpa

0.04

2888

13085

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

494

1335

2.33

60.03

20.3

17.5

1392.58

3855.16

nmol/l

1.04

473

1279

(3016879) Cocaine [Presence] in Urine

2434

10642

1.46

59.76

6.3

1.6

—

(3012544) pH of Venous blood

3598

16851

1.37

59.75

4.7

4.0

7.35

7.38

1.92

115

(3023520) Reticulocytes [#/volume] in Blood

3000

13661

1.40

58.95

2.5

2.6

71.80

70.05

e9/l

1.60

2181

10137

(3007853) Bacteria identified in Skin by Aerobe culture

4986

24552

1.31

58.92

1.8

1.7

—

(3009343) pH of Capillary blood

2478

10935

1.44

57.91

3.9

3.8

7.41

7.42

1.37

367

1342

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2499

11064

1.44

57.38

3.9

3.8

5.19

5.14

kpa

2.60

2365

10481

(3026493) Urate [Moles/volume] in Serum or Plasma

9397

50072

1.22

56.67

2.3

3367.74

3682.38

umol/l

0.37

8146

44464

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

468

1271

2.32

56.28

15.1

12.5

809.39

1616.73

nmol/l

0.52

459

1223

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2399

10582

1.44

56.15

3.8

1.89

1.66

mmol/l

2.35

1799

7701

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8015

42077

1.24

55.50

1.3

31.14

32.02

iu/ml

0.08

2534

13697

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

771

2561

1.90

55.17

1.5

1.2

—

(3022145) Colonoscopy Study observation

4641

22824

1.31

55.08

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

833

2843

1.85

54.88

1.5

1.2

0.80

1.43

nmol/l

0.59

800

2742

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

683

7847

0.54

54.48

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

829

2835

1.85

54.28

1.5

1.2

0.37

0.19

nmol/l

0.95

151

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2301

10156

1.44

53.62

1.7

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3123

14548

1.37

53.36

7.5

7.4

8.34

8.69

mmol/l

2.04

2966

13880

(3003181) Sodium [Moles/volume] in Urine

875

3070

1.80

52.79

1.7

1.4

67.12

62.51

mmol/l

1.97

705

2412

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

364

913

2.51

51.91

3.0

2.1

179.24

149.38

umol/l

0.64

184

474

(3000764) Benzodiazepines [Presence] in Urine

2554

11571

1.41

51.46

6.2

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7608

40005

1.23

51.33

1.3

8.66

11.25

u/ml

2.14

2920

16151

(3047352) Trisomy 18 risk [Likelihood] in Fetus

836

8911

0.58

50.83

1.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4098

20021

1.31

50.77

1.8

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

863

9117

0.58

50.69

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

836

8893

0.58

50.44

1.4

—

(3028300) Cannabinoids [Presence] in Urine

2563

11670

1.40

50.13

6.3

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2285

10197

1.43

50.09

8.5

8.9

0.70

0.12

2272

10135

(3027008) Opiates [Presence] in Urine

2554

11641

1.40

49.65

6.1

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4111

20201

1.30

48.69

1.8

1.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

482

1415

2.15

48.32

12.2

11.9

0.61

0.62

mmol/l

0.33

443

1303

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3029

14261

1.36

48.20

1.7

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2279

10237

1.42

48.13

8.5

8.8

1.45

1.38

2.37

2266

10171

(3014007) Fractional oxyhemoglobin in Arterial blood

2277

10239

1.41

47.79

8.5

8.9

94.03

94.05

0.05

2269

10198

(3010838) Calcium [Moles/time] in 24 hour Urine

991

3770

1.66

44.98

2.0

1.9

5.39

5.13

mmol/24h

1.45

873

3385

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

15096

85283

1.17

44.77

4.1

3.6

—

(3037522) Nuclear Ab [Titer] in Serum

6285

32805

1.23

44.71

1.4

482.10

585.26

titre

4.79

1314

6806

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

716

2500

1.81

43.94

1.4

1.3

505.77

353.26

pmol/l

0.54

630

2209

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

405

5120

0.49

43.80

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1903

8435

1.43

43.19

8.6

9.3

24.35

24.37

mmol/l

0.07

1840

8161

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1893

16420

0.71

43.16

3.9

3.6

22.57

21.65

1.35

735

6794

(3011397) Hemoglobin [Presence] in Urine by Test strip

9442

51459

1.19

42.76

3.8

3.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1371

5719

1.52

42.23

1.4

289.39

287.40

ug/g

0.12

760

3199

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6793

35947

1.22

42.00

3.5

3.4

268.35

375.49

ng/l

1.34

4576

24326

(3046904) Somatotropin [Units/volume] in Serum or Plasma

14.92

41.88

3.2

1.1

1.97

4.02

mu/l

0.83

(3019060) Gas panel - Arterial blood

2300

10593

1.38

41.85

5.0

4.5

—

(3010421) pH of Blood

1169

4724

1.56

41.53

3.7

3.6

7.41

7.42

2.83

1073

4328

(3029937) Albumin [Presence] in Urine by Test strip

10642

58746

1.18

41.23

4.4

3.9

0.00

estimate

0.67

3999

20499

(3005719) IgG [Mass/volume] in Serum or Plasma

3334

16295

1.30

40.73

2.6

2.7

10.17

10.47

g/l

3.91

3000

14969

(40761536) Microorganisms panel - Urine sediment

3815

19005

1.28

40.26

4.3

3.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

571

1913

1.88

39.94

3.7

2.9

5.70

7.43

nmol/l

0.25

543

1848

(3027944) Amphetamines [Presence] in Urine

2451

11491

1.36

39.87

5.7

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1967

8899

1.40

39.76

5.6

4.4

24.28

24.19

mmol/l

0.65

1930

8715

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1355

5713

1.50

39.68

2.1

2.3

438.59

463.98

ug/l

0.11

1225

5244

(3020630) Protein [Mass/volume] in Serum or Plasma

2853

13702

1.33

39.48

2.7

2.4

66.37

66.75

g/l

1.82

2558

12438

(3020191) Ethanol [Moles/volume] in Serum or Plasma

480

1522

1.99

39.40

1.6

1.5

1.20

1.38

promille

1.78

369

1148

(3017181) Myelocytes/100 leukocytes in Blood

3454

17046

1.29

39.16

4.1

0.99

0.93

0.49

1173

5158

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

520

1702

1.92

39.00

1.2

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

894

3446

1.64

38.61

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1762

7880

1.42

38.02

3.7

3.0

1.37

1.28

2.29

1750

7839

(3013290) Carbon dioxide [Partial pressure] in Blood

1016

4058

1.58

37.97

3.8

3.7

5.09

5.00

kpa

3.44

995

3964

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

204

446

2.87

37.84

1.9

1.4

0.19

0.26

nmol/l

1.51

159

316

(3012501) Base excess in Blood by calculation

1015

4057

1.58

37.81

3.8

3.7

2.52

2.47

mmol/l

0.23

717

2668

(3022313) Gas panel - Capillary blood

1755

7854

1.42

37.72

4.0

—

(21494755) Public health laboratory ask at order entry panel

3462

27032

0.78

37.33

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

3298

16282

1.29

37.21

4.1

0.11

0.12

0.43

1017

4415

(3027315) Oxygen [Partial pressure] in Blood

1018

4089

1.57

37.15

3.8

3.7

8.78

8.80

kpa

0.16

997

3994

(3023183) Ammonium ion [Moles/volume] in Plasma

870

3370

1.63

36.87

2.8

33.40

33.71

umol/l

0.09

783

3076

(3048689) Calprotectin [Mass/mass] in Stool

5932

31334

1.22

36.84

2.2

2.4

118.63

118.94

ug/g

0.02

4607

24649

(3002179) Metamyelocytes/100 leukocytes in Blood

3171

15622

1.29

36.33

3.8

3.9

0.68

0.67

0.12

1017

4509

(3009466) Valproate [Moles/volume] in Serum or Plasma

770

2905

1.67

36.14

5.7

5.2

370.79

375.60

umol/l

0.33

656

2563

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2209

10352

1.35

35.96

7.3

6.4

24.77

24.61

mmol/l

1.24

2107

9823

(3004119) Hemoglobin [Mass/volume] in Venous blood

2175

10175

1.36

35.80

4.0

3.4

128.52

128.55

g/l

0.02

2111

9952

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1717

7742

1.40

35.35

3.7

3.0

0.64

0.66

1.73

1709

7711

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1381

6000

1.46

34.82

2.8

3.5

349.68

1773.95

u/ml

2.18

1159

5083

(3041096) Erythrocytes [Presence] in Urine by Automated

10926

61124

1.16

34.44

3.6

3.1

—

(1616796) Gas panel - Central venous blood

972

3940

1.56

34.12

3.6

3.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2352

11263

1.33

33.08

1.6

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

888

3559

1.57

32.75

1.2

1.1

—

(3000494) Fungus identified in Specimen by Culture

4614

24046

1.23

32.41

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2571

12517

1.30

32.09

1.7

1.8

1.27

1.33

g/l

0.91

2366

11486

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

482

1643

1.85

32.08

1.5

1.3

4.68

5.41

umol/l

3.77

445

1514

(3025159) Blasts/100 leukocytes in Blood

3125

15609

1.27

31.98

4.2

0.42

0.29

0.32

844

3797

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1569

7100

1.40

31.63

4.3

4.1

24.90

24.73

mmol/l

1.48

1457

6619

(3020891) Body temperature

1488

6697

1.41

30.96

5.0

4.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1381

11953

0.71

30.81

2.9

2.6

0.66

0.72

ug/l

0.85

875

7010

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

239

3197

0.47

30.56

1.4

1.6

7.82

7.59

mmol/l

0.89

233

3064

(3019150) Specific gravity of Urine by Refractometry

8702

48223

1.16

30.39

4.6

3.8

1.02

kg/l

0.49

1239

7460

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

388

1262

1.93

29.78

1.5

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

1296

5732

1.43

29.74

4.1

3.8

1.30

1.35

mmol/l

0.94

1277

5631

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1415

6360

1.41

29.67

2.7

2.8

3.53

3.55

g/l

0.21

1333

6034

(40767503) Oxygen content in Capillary blood by calculation

899

3710

1.53

29.17

2.6

2.4

16.49

16.51

0.05

464

1835

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1877

8880

1.34

28.64

1.9

2.0

39.74

39.75

u/l

0.01

1673

8060

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

782

3143

1.57

28.55

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2080

10002

1.32

28.35

2.4

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

784

3162

1.56

28.20

2.8

3.4

857.71

528.44

u/ml

0.36

699

2874

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2655

20698

0.79

27.75

4.5

4.1

1.60

2.59

ug/l

4.82

2325

18651

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1408

6400

1.39

27.66

2.3

2.6

178.95

177.15

0.32

1334

6021

(3004588) Protein electrophoresis panel - Serum or Plasma

2258

11028

1.30

27.46

2.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

707

2806

1.59

27.25

2.0

1.8

1.66

1.69

mmol/l

0.38

696

2736

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1135

4981

1.44

27.19

1.6

1.2

4.50

3.31

ug/l

1.23

938

4610

(3043409) Potassium [Moles/volume] in Arterial blood

1128

4958

1.44

26.80

4.4

4.0

3.79

3.83

mmol/l

2.46

1120

4913

(3007566) Smooth muscle Ab [Titer] in Serum

1322

6002

1.39

26.16

1.2

1.3

109.15

131.54

titre

0.60

129

553

(3025941) Bacteria identified in Stool by Culture

2726

13733

1.26

25.83

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3103

15864

1.24

25.83

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

236

2988

0.49

25.81

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1154

5131

1.42

25.75

1.7

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1570

7366

1.35

25.32

4.0

3.8

49.70

48.56

1.03

1546

7292

(3015235) Bicarbonate [Moles/volume] in Capillary blood

979

4236

1.46

25.29

3.1

3.2

24.94

24.72

mmol/l

0.91

952

4136

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3752

19630

1.22

25.01

1.2

126.89

150.57

iu/ml

3.32

1349

7663

(3052851) Hemolysis interference index of Serum or Plasma

1315

6012

1.38

24.97

2.9

2.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

621

2441

1.60

24.96

2.4

2.6

44.93

743.87

u/ml

1.11

609

2419

(40768793) Breast Pathology biopsy report

1359

6251

1.37

24.87

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

272

834

2.05

24.69

1.4

13.65

14.53

pmol/l

2.01

228

699

(3001556) Androgen free Index in Serum or Plasma

130

283

2.88

24.50

1.7

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1481

6922

1.35

24.49

2.5

95.19

94.75

0.30

1413

6614

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

364

1240

1.85

24.42

3.3

2.8

139.29

101.11

nmol/l

1.15

357

1214

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4134

30407

0.84

24.18

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3088

15901

1.23

24.00

2.4

2.3

24.57

22.53

au/ml

0.42

204

1434

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

239

706

2.13

23.90

2.1

2.3

148.40

159.78

nmol/l

0.85

205

620

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

511

1935

1.66

23.83

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

726

2992

1.53

23.80

2.8

2.9

—

(40761535) Cells panel - Urine sediment

3098

15973

1.23

23.78

3.6

3.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1162

5252

1.40

23.64

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1676

8023

1.32

23.58

3.6

3.3

25.32

25.34

mmol/l

0.06

1626

7772

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1840

8923

1.30

23.57

9.5

9.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

463

1719

1.69

23.26

1.1

—

(3036489) Thrombin time

1696

8152

1.32

23.18

2.0

2.2

21.25

21.28

0.06

1445

6946

(3024980) IgG subclass 4 [Mass/volume] in Serum

827

3531

1.48

22.90

1.5

0.64

0.67

g/l

0.31

562

2730

(3044290) Cell count panel - Cerebral spinal fluid

1025

4580

1.41

22.30

1.4

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

524

2033

1.62

22.27

6.5

6.4

11.31

11.50

mg/l

0.37

472

1871

(3017143) Hepatitis C virus Ab [Presence] in Serum

5466

29858

1.17

22.18

1.7

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1213

5592

1.37

21.92

1.9

2.1

10.36

10.50

mg/l

0.18

1114

5247

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1153

5278

1.38

21.77

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2832

14609

1.23

21.59

1.3

44.62

50.22

au/ml

0.60

105

732

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1628

7859

1.31

21.57

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

900

3963

1.43

21.26

3.0

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1492

7131

1.32

21.24

1.9

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1065

4833

1.39

21.20

1.2

1.4

3.67

3.64

mmol/l

0.43

996

4541

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1191

5505

1.36

21.18

1.3

1.4

518.24

490.94

mg/l

0.49

1138

5254

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

197

3.12

21.15

3.2

2.6

86.61

54.48

pmol/l

0.64

170

(3036603) Volume of Urine

341

1196

1.79

20.93

1.5

2008.10

1969.04

0.29

332

1165

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

375

1357

1.74

20.71

6.2

6.4

—

(4200892) Spirometry reversibility

2800

14491

1.22

20.67

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

583

2364

1.55

20.63

1.2

1.3

40.69

35.37

u/l

0.26

502

2082

(3016038) Potassium [Moles/volume] in Urine

342

1208

1.78

20.52

1.6

1.3

35.18

33.99

mmol/l

0.38

294

1040

(3049717) Cytology report of Urine Cyto stain

1039

4735

1.38

20.18

2.3

2.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1064

4874

1.38

20.03

1.4

1.5

38.31

26.75

e6/l

0.40

826

3773

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

170

470

2.27

20.03

1.5

1.6

0.44

0.39

ug/l

0.68

110

315

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1063

4880

1.37

19.75

1.4

1.5

4523.49

1436.67

e6/l

0.44

876

3956

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

196

3.04

19.70

6.8

7.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

168

3.21

19.46

2.9

1.6

16.73

2.29

nmol/l

1.67

156

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3544

18869

1.19

19.42

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

1380

6629

1.31

18.98

3.0

3.2

0.23

0.33

g/l

3.70

566

2716

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1540

7517

1.29

18.82

1.7

1.8

1.52

1.48

g/l

0.68

1301

6458

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1283

6112

1.32

18.72

2.2

1.9

2.04

2.18

ug/l

0.19

1121

5355

(37021550) Renin [Units/volume] in Plasma --upright

143

378

2.37

18.66

1.6

1.3

69.52

92.73

mu/l

0.49

112

293

(36660697) Celiac disease serology panel - Serum

3812

20507

1.18

18.50

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1740

8651

1.27

18.38

1.8

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

472

1882

1.58

18.04

3.9

3.3

—

(3024928) Oxygen saturation in Venous blood

799

3571

1.41

17.46

4.5

3.5

—

(3017732) Neutrophils [#/volume] in Blood

2939

15531

1.20

17.46

2.9

2.6

4.59

4.69

e9/l

0.15

2305

12978

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1964

9972

1.24

17.33

1.3

1.19

0.92

u/ml

0.36

190

831

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

940

4335

1.37

17.04

3.6

37.23

36.45

u/ml

0.05

914

4184

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

982

4565

1.36

16.93

1.4

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

144

3.22

16.90

1.6

1.3

9.94

16.67

pmol/l

0.85

119

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

543

2271

1.50

16.78

2.1

2.0

26.73

24.44

mg/l

0.38

164

597

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

546

2287

1.50

16.75

4.8

4.3

102.79

110.36

u/ml

0.09

165

728

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2631

13825

1.20

16.60

2.4

2.2

5.76

6.53

ug/l

1.31

2181

11935

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1333

6494

1.29

16.57

1.8

2.0

10.47

21.23

iu/l

0.48

488

2538

(3022806) Fractional oxyhemoglobin in Capillary blood

561

2369

1.49

16.56

1.9

1.7

89.92

90.50

1.48

552

2332

(3034770) Mitochondria Ab [Titer] in Serum

1238

5975

1.31

16.50

1.2

1.3

656.49

1000.64

titre

1.49

202

(3016244) Insulin [Units/volume] in Serum or Plasma

455

1838

1.56

16.49

3.1

3.3

25.50

27.15

mu/l

0.37

429

1743

(3034860) Kappa light chains.free [Mass/volume] in Serum

1012

4752

1.34

16.35

3.4

3.2

46.68

76.00

mg/l

0.99

811

3845

(3028626) Oxygen [Partial pressure] in Capillary blood

985

4609

1.35

16.29

4.4

4.1

8.70

8.73

kpa

0.23

962

4486

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1009

4741

1.34

16.23

3.4

3.2

36.07

45.90

mg/l

0.98

805

3840

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2971

15835

1.19

16.02

2.5

70.49

69.17

ml/min/173m2

0.79

1196

6186

(3000012) Reticulocyte production index

497

2062

1.52

15.98

2.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2015

10362

1.23

15.81

1.1

10.90

9.67

u/ml

0.04

158

(3020717) Zinc [Moles/volume] in Serum or Plasma

331

1250

1.66

15.80

1.7

1.5

23.87

25.35

umol/l

0.39

317

1195

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

676

2988

1.42

15.77

1.6

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

979

4604

1.34

15.68

3.3

3.1

2.75

2.08

ratio

0.25

381

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

814

3726

1.38

15.50

1.5

1.6

—

(40768443) Skin Pathology biopsy report

1792

9122

1.24

15.47

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

473

1956

1.52

15.46

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1044

4969

1.32

15.40

3.6

3.5

0.36

0.35

u/ml

0.19

592

2818

(4062490) Immunoglobulin typing, IgG

544

2318

1.48

15.40

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

580

2504

1.46

15.36

3.5

3.9

44.71

47.03

u/ml

0.15

574

2475

(3030313) Adrenal Ab [Titer] in Serum

106

268

2.48

15.28

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

216

732

1.85

14.97

2.7

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

727

3287

1.39

14.93

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

644

2854

1.42

14.84

3.3

3.0

1.41

1.52

0.34

584

2540

(3007930) Methemoglobin/Hemoglobin.total in Blood

1370

6794

1.27

14.83

5.5

4.7

0.90

0.14

1285

6366

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1386

6887

1.27

14.77

5.4

4.6

1.67

1.68

0.16

1298

6448

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2622

13924

1.19

14.73

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

539

2314

1.46

14.72

1.4

6.32

6.73

g/l

1.76

325

1672

(3024139) IgG subclass 3 [Mass/volume] in Serum

538

2311

1.46

14.65

1.4

0.39

0.40

g/l

0.13

329

1670

(3028192) IgG subclass 2 [Mass/volume] in Serum

538

2312

1.46

14.62

1.4

2.81

2.92

g/l

0.79

327

1668

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1857

9552

1.23

14.55

2.7

2.5

0.27

e6/l

0.02

1795

9187

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1365

6788

1.27

14.46

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

927

4386

1.33

14.29

1.6

1.7

9912.99

12081.66

e6/l

1.01

667

3191

(3014765) Yersinia sp identified in Stool by Organism specific culture

1376

6864

1.26

14.21

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1378

6877

1.26

14.18

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

587

2581

1.43

14.15

1.5

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1069

5168

1.30

14.14

2.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1087

5278

1.30

13.92

5.3

4.8

1.42

1.38

mg/l

0.78

995

4930

(3024522) Salmonella sp identified in Specimen by Organism specific culture

591

2611

1.42

13.89

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

586

2588

1.42

13.81

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2419

12833

1.19

13.74

1.1

122.57

219.84

titre

1.65

338

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

250

911

1.72

13.68

2.2

2.1

29.80

28.56

umol/l

1.04

244

882

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1201

9464

0.79

13.67

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

601

2672

1.41

13.65

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

584

2586

1.42

13.57

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

588

2607

1.42

13.57

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

966

4634

1.31

13.54

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

408

1686

1.52

13.46

1.2

1.3

2.04

1.98

mmol/l

0.50

373

1558

(3016018) Differential panel - Cerebral spinal fluid

551

2420

1.43

13.40

1.4

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

159

507

1.97

13.25

2.5

1.3

5.43

5.50

nmol/l

0.06

152

478

(3013005) Retinol [Moles/volume] in Serum or Plasma

278

1057

1.65

13.04

2.1

2.0

1.92

umol/l

0.06

263

996

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

871

4141

1.32

13.03

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

764

3563

1.35

13.02

3.3

3.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

885

4222

1.32

12.93

2.3

2.1

129.75

129.67

g/l

0.03

653

3076

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1381

6970

1.25

12.92

1.3

35.15

35.76

u/ml

0.03

454

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1274

6377

1.26

12.82

1.3

8.02

9.08

u/ml

0.21

200

1028

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

899

4304

1.31

12.81

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1254

6280

1.26

12.57

1.3

3.15

7.20

u/ml

2.65

138

658

(3042631) Mycobacterium sp identified in Specimen

468

2038

1.44

11.98

2.5

2.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

550

2467

1.40

11.95

1.6

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1617

8371

1.22

11.94

1.4

1.5

11.32

14.56

u/ml

0.53

235

(3006653) Thiamine [Moles/volume] in Blood

261

1002

1.63

11.85

1.3

1.4

136.69

134.02

nmol/l

0.42

261

1002

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

536

2402

1.40

11.72

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

256

984

1.63

11.58

1.2

151.74

149.01

mmol/24h

0.19

256

984

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1083

5385

1.27

11.57

1.3

38.86

43.18

u/ml

0.40

125

528

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1405

7203

1.23

11.43

1.7

1.8

0.23

g/l

0.68

1341

6840

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1715

8971

1.21

11.40

1.6

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1439

7404

1.22

11.31

1.7

1.8

1.20

1.17

g/l

2.00

1376

7048

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1073

5348

1.26

11.25

2.3

0.49

0.78

g/l

2.94

902

4624

(3027456) Digoxin [Moles/volume] in Serum or Plasma

607

2799

1.36

11.20

3.2

0.81

0.82

nmol/l

0.23

465

2182

(3014271) Vancomycin [Susceptibility]

203

743

1.71

11.05

2.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

8305

55855

0.91

11.04

2.1

1.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.57

11.01

1.4

485.65

527.30

nmol/l

0.17

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1241

6305

1.24

11.00

2.1

7.49

7.39

g/l

1.02

1100

5669

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

499

2235

1.40

10.98

1.2

60.75

61.20

u/l

0.06

452

2014

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1239

6296

1.24

10.97

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1237

6288

1.24

10.92

2.1

3.59

3.65

g/l

0.71

1097

5659

(3044927) Protein electrophoresis panel - Urine

348

1457

1.50

10.91

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1081

5413

1.26

10.91

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3328

23488

0.88

10.85

1.7

1.6

—

(3045414) Leukocytes [Presence] in Urine

1877

9952

1.19

10.78

1.9

1.8

—

(3012565) Volume of 24 hour Urine

242

935

1.62

10.77

2.0

2.1

1999.79

2000.77

0.00

220

852

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1178

5974

1.24

10.64

2.2

2.92

2.93

g/l

0.12

1038

5339

(3000330) Specific gravity of Urine by Test strip

1830

9695

1.19

10.61

3.6

3.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

102

301

2.12

10.54

2.2

1.7

45.87

54.37

pmol/l

0.30

256

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6939

46957

0.91

10.50

1.8

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

637

2991

1.34

10.48

2.9

3.3

19180.03

1211.79

u/ml

0.52

160

(3008037) Lactate [Moles/volume] in Venous blood

742

3566

1.31

10.38

3.0

1.55

1.50

mmol/l

0.78

720

3497

(4146454) Self-monitoring of blood glucose

386

1668

1.45

10.37

2.6

2.7

—

(3021788) Differential panel - Synovial fluid

704

3366

1.31

10.23

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

386

1.97

10.20

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

142

1567

0.57

10.20

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1156

5888

1.24

10.05

2.1

9.82

10.14

g/l

1.54

1004

5225

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

310

1290

1.51

10.05

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

983

4921

1.26

9.98

2.2

2.1

37.75

38.16

g/l

1.29

841

4273

(3005322) IgE [Units/volume] in Serum or Plasma

2948

16297

1.14

9.86

1.3

184.98

215.33

u/ml

0.87

2724

15084

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

268

1085

1.55

9.86

1.3

61.15

65.41

0.29

140

(3023410) Appearance of Cerebral spinal fluid

503

2301

1.37

9.82

1.5

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

809

0.42

9.71

1.2

—

(40768800) Prostate Pathology biopsy report

1085

0.50

9.67

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1296

6709

1.22

9.65

1.6

304.34

306.50

titre

0.01

300

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

354

1528

1.45

9.61

2.6

2.7

—

(3045424) Erythrocytes [Presence] in Urine

751

3665

1.29

9.42

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

890

4438

1.26

9.37

4.6

4.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1046

5317

1.24

9.30

1.5

1.4

20.37

14.17

iu/ml

0.53

139

(3045142) Bone marrow Pathology biopsy report

389

1721

1.42

9.27

1.4

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

291

1217

1.50

9.26

1.1

10.06

4.28

nmol/l

0.42

219

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

336

1449

1.46

9.19

1.8

2.4

100.68

98.86

0.47

311

1329

(3036670) Protein [Mass/volume] in Synovial fluid

133

455

1.83

9.17

1.3

1.2

37.87

39.17

g/l

0.47

236

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

436

1972

1.39

9.16

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

390

1731

1.41

9.13

3.2

3.1

56.66

56.27

0.13

340

1457

(3006922) Hepatitis E virus Ab [Presence] in Serum

351

1532

1.44

9.02

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

442

2010

1.38

9.00

2.0

2.1

32.24

32.35

0.19

437

1995

(3047181) Lactate [Moles/volume] in Blood

1106

5677

1.23

8.99

6.2

5.1

1.28

1.26

mmol/l

0.23

986

5027

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

832

4141

1.26

8.93

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1500

7933

1.19

8.92

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2552

14067

1.14

8.92

2.7

2.8

166.38

172.62

ng/l

0.28

2284

12708

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

685

3328

1.29

8.92

1.4

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

832

4142

1.26

8.91

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2731

15127

1.14

8.88

2.3

2.2

5695.98

6110.56

u/l

0.27

895

6220

(1002224) Polysomnography panel

1751

9388

1.17

8.87

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

130

450

1.81

8.67

1.2

346.16

356.63

pmol/l

0.08

342

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

266

1111

1.50

8.56

1.7

1.6

—

(3037756) Immunofixation for Serum or Plasma

649

3150

1.29

8.54

1.7

—

(40768441) Liver Pathology biopsy report

336

1472

1.43

8.50

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

373

1666

1.41

8.47

1.2

1.1

—

(3018133) Calcium [Moles/volume] in Urine

123

422

1.83

8.45

1.9

2.5

2.78

2.58

mmol/l

0.48

113

383

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

149

542

1.72

8.43

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

447

2061

1.36

8.39

19.0

6.4

7.72

7.14

mmol/l

0.91

368

1681

(3044941) Cell count panel - Synovial fluid

593

2854

1.31

8.32

1.4

—

(40768806) Pleura Pathology biopsy report

297

1277

1.46

8.30

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

795

3975

1.26

8.25

5.2

5.7

581.26

1269.04

iu/ml

0.93

567

(3039000) Anion gap in Blood

764

3803

1.26

8.23

7.5

6.1

11.15

11.14

mmol/l

0.04

689

3414

(3018572) Chloride [Moles/volume] in Blood

764

3804

1.26

8.21

7.5

6.1

105.24

105.23

mmol/l

0.02

689

3415

(3038515) Glucose [Moles/volume] in Venous blood

682

3352

1.28

8.16

3.2

3.0

7.42

7.34

mmol/l

0.29

663

3293

(21494815) CD4 cells/100 lymphocytes in Specimen

399

1816

1.38

8.13

2.3

39.74

40.79

0.72

389

1786

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

963

1.52

8.10

1.6

1.8

1.28

1.29

nmol/l

0.00

178

777

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

399

1819

1.38

8.06

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

351

1566

1.41

8.05

2.3

1.9

22.79

24.58

ug/l

0.28

342

1538

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

741

3687

1.26

8.02

2.4

0.87

0.83

nmol/l

0.81

615

3123

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

990

5091

1.22

7.96

1.2

1.3

4.65

5.97

u/ml

0.23

399

(3013336) Amino acids [Identifier] in Serum or Plasma

2.98

7.86

3.8

2.4

—

(3019977) pH of Arterial blood

214

871

1.54

7.81

2.8

2.5

7.42

0.32

283

(3023511) Choriogonadotropin [Units/volume] in Urine

1461

7806

1.18

7.77

1.5

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

465

2185

1.34

7.76

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

961

4942

1.22

7.74

1.2

23.41

11.48

u/ml

0.38

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

269

1152

1.46

7.71

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

863

4401

1.23

7.54

2.3

2.1

0.00

g/l

1.48

783

4003

(3033705) Calcium.ionized [Moles/volume] in Venous blood

416

1934

1.35

7.47

2.4

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1417

7579

1.18

7.46

1.8

1.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

477

2264

1.32

7.45

1.6

50.65

52.77

0.51

297

1412

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

288

1260

1.43

7.41

1.3

1.5

5.96

5.66

u/l

0.26

243

1042

(3010144) Erythrocytes [#/volume] in Synovial fluid

363

1656

1.38

7.35

1.4

88981.58

84823.94

e6/l

0.04

231

1143

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

314

1400

1.41

7.28

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

329

1.87

7.27

2.5

2.6

18.71

47.29

mg/l

1.81

(40757494) Bilirubin.total [Moles/volume] in Blood

218

906

1.51

7.27

2.1

2.4

27.10

27.76

umol/l

0.02

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

928

4790

1.22

7.24

2.3

2.1

0.00

0.02

g/l

3.07

845

4380

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

425

1994

1.34

7.20

1.7

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

172

679

1.59

7.20

2.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

362

1657

1.37

7.19

1.4

34.84

33.00

g/l

1.76

327

1500

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

149

2.31

7.10

3.4

2.6

165.18

79.29

pmol/l

0.30

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

849

4352

1.23

7.09

2.3

2.1

0.00

g/l

-0.00

780

3994

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

314

1410

1.40

7.01

1.1

—

(3028433) Virus identified in Specimen by Culture

168

665

1.58

6.97

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

476

3852

0.77

6.96

1.3

1.4

7.25

6.84

mmol/l

2.58

425

3471

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

731

3696

1.24

6.96

1.2

100.00

141.82

titre

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

267

1171

1.43

6.82

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5926

39686

0.92

6.75

2.3

2.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

728

3695

1.24

6.71

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

382

1785

1.34

6.69

1.7

1.6

—

(3023419) Bacteria identified in Sputum by Culture

496

2406

1.29

6.67

2.6

2.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

332

1519

1.37

6.66

1.4

2325.29

3649.34

e6/l

1.15

237

1096

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.73

6.65

1.6

1.7

8.56

18.86

1.42

(3029396) Erythrocyte agglutination [Presence] in Blood

104

1103

0.59

6.62

2.9

3.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

184

754

1.53

6.60

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1847

10175

1.14

6.59

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2302

16110

0.89

6.56

1.4

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

503

1.65

6.42

3.1

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

132

503

1.65

6.42

3.1

2.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

292

1317

1.39

6.40

1.6

6.93

6.51

u/l

0.20

241

1061

(3001186) Copper [Moles/volume] in Serum or Plasma

143

557

1.61

6.38

1.5

1.4

17.37

17.48

umol/l

0.09

127

496

(3028308) Erythrocytes [#/volume] in Pleural fluid

301

1367

1.38

6.34

1.4

63447.62

42790.07

e6/l

0.47

172

792

(4034850) Laboratory test

1269

6823

1.17

6.33

8.6

8.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

365

1711

1.34

6.29

2.5

0.91

1.36

g/24h

3.68

163

832

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

266

1185

1.41

6.28

1.3

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

278

1250

1.40

6.22

1.7

127.40

132.26

0.56

260

1180

(3017509) Phencyclidine [Presence] in Urine

297

1.84

6.20

2.8

1.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

115

2.40

6.18

1.6

1.3

13.98

17.85

pmol/l

0.73

(3042301) Urate [Moles/volume] in Synovial fluid

4.77

6.16

1.0

363.00

314.04

umol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

339

1578

1.35

6.14

1.5

1.3

1.60

1.43

nmol/l

1.67

303

1427

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

285

1295

1.38

6.01

1.3

1.2

83.31

84.75

u/l

0.10

253

1136

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

201

858

1.47

5.98

1.6

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

261

1170

1.40

5.97

1.3

1.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.64

5.97

1.8

1.6

184.43

189.53

ng/l

0.15

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

526

2612

1.26

5.93

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

278

1262

1.38

5.91

1.3

1.2

23.53

21.67

u/l

0.26

241

1084

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

225

1977

0.71

5.85

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

203

873

1.46

5.83

1.6

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

209

904

1.45

5.83

1.6

1.3

123.52

176.37

pmol/l

3.51

209

904

(3022621) pH of Urine by Test strip

2522

14270

1.11

5.82

3.1

2.9

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

651

4973

0.82

5.81

2.1

2.2

6.52

6.08

umol/l

0.26

482

3614

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

322

1503

1.34

5.76

2.5

2.6

728.40

769.15

e6/l

0.46

309

1458

(3044242) Glucose [Moles/volume] in Arterial blood

174

729

1.50

5.70

2.1

2.0

—

(3010503) CD19 cells [#/volume] in Blood

263

1192

1.38

5.66

2.5

2.6

0.20

0.32

e9/l

0.67

253

1164

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

26369

168303

0.95

5.66

3.3

3.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

635

3245

1.23

5.58

1.1

53.86

3485.80

iu/ml

0.66

153

796

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

484

2400

1.27

5.56

1.5

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

192

1.99

5.55

1.2

1.1

58.24

40.62

mg/l

1.43

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

193

1.98

5.48

2.1

2.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

348

1657

1.32

5.46

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

970

1.42

5.41

1.5

—

(3045788) Cell count panel - Pleural fluid

259

1183

1.37

5.35

1.4

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

1049

5641

1.17

5.29

2.6

2.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

237

1069

1.39

5.29

1.2

1.1

78.90

81.99

u/l

0.19

220

968

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

345

1651

1.31

5.24

1.4

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

343

1642

1.31

5.20

1.1

299.52

477.75

mg/l

0.49

307

1475

(3011412) CD3 cells [#/volume] in Blood

434

2143

1.27

5.19

2.4

2.5

1.28

1.29

e9/l

0.08

390

1885

(3023487) Leukocytes [#/volume] in Peritoneal fluid

129

518

1.56

5.17

1.9

2.0

4703.34

944.60

e6/l

0.47

339

(3019420) Tryptase [Mass/volume] in Serum or Plasma

290

1358

1.34

5.13

1.6

1.5

9.41

7.40

ug/l

0.63

258

1223

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

609

3128

1.22

5.13

1.5

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

619

3185

1.22

5.13

1.2

1.3

46.68

55.85

u/ml

0.44

222

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

236

1071

1.38

5.10

1.2

1.1

25.90

21.38

u/l

0.37

218

972

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

317

1.72

5.08

1.6

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

694

5196

0.83

5.07

1.1

1.72

2.16

u/ml

0.67

326

2657

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

201

888

1.42

5.07

1.1

99.81

95.03

0.82

404

(3004451) EKG impression Narrative

173

743

1.46

5.07

1.2

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

208

925

1.41

5.06

1.1

1.2

114.27

111.62

0.47

187

833

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

318

1.71

5.03

1.2

1.1

16.68

3.88

pmol/l

0.41

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

199

879

1.42

5.03

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

555

2830

1.23

5.03

1.3

—

(3006270) Folate [Moles/volume] in Blood

356

1722

1.30

5.02

1.2

1.1

381.60

384.25

nmol/l

0.09

313

1503

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

199

880

1.42

5.00

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

596

3065

1.22

4.98

1.6

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

250

1.80

4.95

2.6

3.0

806.17

2192.86

u/l

1.13

233

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

201

1.90

4.92

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

595

3064

1.22

4.91

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

112

2.24

4.91

1.9

1.7

65.62

55.71

0.84

(3033923) Metanephrine [Moles/time] in 24 hour Urine

112

441

1.59

4.90

1.2

1.1

0.58

0.66

umol/24h

0.79

224

(3033799) Differential panel - Peritoneal fluid

112

442

1.59

4.85

2.0

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

246

1134

1.36

4.85

1.0

1.1

94.89

94.97

0.01

196

901

(4094501) Cardiovascular stress test using bicycle ergometer

914

4906

1.17

4.77

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

159

681

1.46

4.75

1.3

31.62

19.14

1.03

130

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

201

900

1.40

4.73

1.7

138.99

150.10

1.22

186

847

(3012441) Differential panel - Pleural fluid

274

1290

1.33

4.72

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

237

1092

1.36

4.70

1.3

509.78

407.44

u/l

0.40

222

1037

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.84

4.70

1.4

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

266

1249

1.34

4.67

1.2

1.3

6.26

6.37

mmol/l

0.27

240

1167

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

392

1940

1.27

4.66

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

389

0.43

4.65

2.5

3.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

445

2236

1.25

4.65

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

388

0.44

4.63

5.0

6.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

184

815

1.42

4.62

2.0

2.1

64.83

65.46

ug/l

0.03

176

796

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

238

1.79

4.59

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

317

1531

1.30

4.57

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

317

1531

1.30

4.57

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

317

1531

1.30

4.57

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5386

35706

0.94

4.55

2.2

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

202

913

1.39

4.52

1.1

94.06

94.25

0.03

413

(3032057) Clostridioides difficile [Presence] in Stool

387

1.60

4.50

1.7

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

330

1.65

4.45

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

164

717

1.43

4.44

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

190

853

1.40

4.44

1.2

111.20

111.16

0.01

178

753

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

260

1227

1.33

4.44

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.56

4.42

1.2

1.27

1.26

u/field

0.01

(21494434) Karyotype in Bone marrow

282

1347

1.31

4.42

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

112

454

1.55

4.38

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

288

1384

1.30

4.33

1.1

1.05

1.04

u/l

0.06

135

591

(3009015) Lactate [Moles/volume] in Synovial fluid

166

1.92

4.31

1.2

1.3

5.41

5.49

mmol/l

0.04

(3016228) CD19 cells/100 cells in Blood

179

800

1.40

4.30

2.1

9.05

8.77

0.10

173

782

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

110

446

1.55

4.30

1.6

1.9

39.17

29.51

u/l

0.26

402

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

187

843

1.39

4.28

1.1

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

8555

55851

0.95

4.26

1.4

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

131

553

1.48

4.26

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

692

3670

1.18

4.23

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

246

1161

1.33

4.22

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

175

783

1.40

4.19

2.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

390

1.57

4.17

1.0

74.11

78.68

ug/l

0.56

323

(3043410) Blood group antigens tested for on Red Blood Cells

127

537

1.48

4.11

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

296

1439

1.29

4.11

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

140

604

1.45

4.10

2.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

353

1756

1.26

4.08

2.1

2.2

73.49

73.51

0.01

341

1698

(21494890) Protein electrophoresis panel - 24 hour Urine

301

1469

1.28

4.06

2.2

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

407

2059

1.24

4.06

3.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

589

4376

0.84

4.04

1.1

4.07

4.58

u/ml

0.28

250

2109

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

550

1.47

4.02

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

282

1368

1.29

3.99

1.8

1.9

3.63

3.56

mg/l

0.08

262

1312

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.85

3.98

1.2

1.1

—

mmol/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

159

707

1.41

3.97

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

159

707

1.41

3.97

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

307

1.63

3.96

1.1

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.90

3.90

2.6

2.0

1679.80

1702.70

umol/l

—

(3044007) Cell count panel - Peritoneal fluid

101

412

1.54

3.89

2.0

1.9

—

(3017569) Oxygen content in Arterial blood

155

689

1.41

3.89

2.0

2.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

353

1.58

3.87

1.4

1.3

14.91

12.98

g/l

0.96

259

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

194

1624

0.75

3.86

1.3

1.4

5.65

5.43

mmol/l

2.52

184

1536

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

329

1635

1.26

3.86

2.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

200

929

1.35

3.85

1.2

0.31

0.30

g/l

1.24

166

728

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

170

1449

0.73

3.83

1.2

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

528

2762

1.20

3.81

1.7

1.6

2455.38

2746.67

titre

0.08

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

104

2.11

3.81

1.1

1.0

0.05

0.13

u/ml

0.87

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

313

1551

1.27

3.77

3.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

111

466

1.49

3.76

1.8

15153.77

9277.63

e6/l

0.28

234

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

200

934

1.34

3.74

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1316

7378

1.12

3.72

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

406

2076

1.23

3.71

1.1

1.2

35.53

39.54

mg/l

1.02

325

1729

(3027974) Hepatitis B virus e Ag [Presence] in Serum

127

1.97

3.68

1.3

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

209

986

1.33

3.66

1.4

1.5

12.09

12.28

u/l

0.14

201

955

(3035947) Staphylolysin Ab [Units/volume] in Serum

198

928

1.34

3.63

1.2

1.1

3.91

3.44

iu/ml

0.24

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

344

1734

1.24

3.60

2.2

13.22

13.73

0.49

338

1693

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.67

3.57

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

297

1.60

3.54

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

2.00

3.53

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

125

545

1.44

3.53

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

558

4110

0.85

3.51

1.1

3.57

5.44

u/ml

2.04

204

1745

(3045716) Anion gap in Serum or Plasma

164

751

1.37

3.50

2.8

2.5

9.95

9.72

mmol/l

0.34

159

733

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.16

3.48

1.1

1.0

0.02

0.08

u/ml

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

160

731

1.37

3.47

2.7

2.8

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.88

3.46

1.3

1.4

0.57

0.78

u/field

—

(3022229) Phosphate [Moles/volume] in Urine

166

1.81

3.46

1.9

2.8

20.68

19.97

mmol/l

0.08

147

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

581

3095

1.18

3.46

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

109

465

1.47

3.45

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.61

3.44

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1337

7544

1.11

3.40

1.1

3.39

5.34

u/ml

1.64

168

1037

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

380

1.52

3.40

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

123

539

1.43

3.39

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

345

1753

1.23

3.39

1.2

77.47

64.59

u/ml

0.32

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.71

3.36

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

119

520

1.43

3.34

1.4

1.2

—

(40762814) Titanium [Mass/volume] in Blood

234

1.66

3.33

2.5

2.3

3.09

4.36

ug/l

1.32

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

347

1769

1.23

3.31

1.2

161.11

194.09

titre

0.35

325

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

345

1758

1.23

3.31

1.2

30.34

46.90

u/ml

0.96

136

(3025577) Chromium [Mass/volume] in Blood

178

834

1.34

3.31

2.1

2.35

2.67

ug/l

0.57

147

711

(3035320) C reactive protein [Mass/volume] in Body fluid

320

1618

1.24

3.30

2.5

2.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

264

1.61

3.28

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

201

961

1.31

3.25

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

800

4389

1.14

3.25

3.9

3.2

22.74

24.88

mg/l

0.90

491

2669

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

117

513

1.43

3.24

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

345

1764

1.23

3.22

1.2

270.00

204.07

titre

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

189

1.72

3.21

1.6

1.4

95.68

120.56

ug/l

0.81

160

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

856

6067

0.88

3.20

1.1

2.41

2.19

u/ml

0.21

410

3084

(3038026) Centromere Ab [Units/volume] in Serum

352

1805

1.22

3.19

1.2

1.3

54.20

49.66

u/ml

0.08

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

480

3546

0.85

3.18

1.0

1.1

0.17

0.38

u/ml

1.45

117

938

(3002331) Protein [Mass/volume] in Peritoneal fluid

306

1.56

3.17

1.4

29.68

26.16

g/l

0.95

223

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

389

2017

1.21

3.16

1.1

231.32

232.93

mg/l

0.07

334

1765

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

521

2774

1.18

3.16

1.1

1.49

1.48

g/l

0.37

472

2512

(3017315) Amylase [Enzymatic activity/volume] in Urine

230

1125

1.28

3.15

1.3

1.2

265.51

291.91

u/l

0.20

212

1055

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

153

1282

0.75

3.15

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

171

803

1.33

3.15

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1688

9682

1.10

3.13

1.6

3.70

3.81

mg/l

0.20

1285

6957

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

235

1154

1.28

3.13

1.3

1.2

576.67

438.82

titre

0.15

(3004716) Salmonella sp identified in Stool by Organism specific culture

2429

14149

1.08

3.12

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

192

920

1.31

3.08

2.6

2.5

53.93

49.93

umol/l

0.87

159

809

(1761868) Lipid panel - Serum or Plasma

13462

82135

1.04

3.08

2.8

2.5

—

(3047189) Immunofixation for 24 hour Urine

135

614

1.38

3.06

2.1

1.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

228

1122

1.27

3.00

1.3

1.2

52.50

58.08

titre

0.11

104

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1724

11729

0.92

2.98

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

221

1085

1.28

2.97

2.7

2.8

43.57

41.94

0.66

115

639

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1199

6783

1.11

2.96

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1103

6215

1.11

2.94

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

567

4105

0.86

2.93

1.2

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

134

1.82

2.92

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

338

1.50

2.91

2.2

2.3

6.90

7.35

mmol/l

0.53

195

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

371

1933

1.20

2.90

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

573

1.38

2.88

1.5

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.02

2.87

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

118

531

1.39

2.87

1.2

1.3

110.91

121.10

nmol/l

0.34

390

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

937

1.29

2.85

1.8

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

121

548

1.38

2.84

1.1

90.71

86.85

0.24

116

(3024263) Appearance of Synovial fluid

191

927

1.29

2.83

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

179

862

1.30

2.81

2.0

3.22

3.93

ug/l

0.75

162

796

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

939

1.29

2.81

1.8

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

210

1033

1.27

2.80

1.0

495.26

324.28

ng/l

0.52

160

738

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

326

1685

1.21

2.79

1.2

5.50

10.71

u/ml

0.86

143

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4385

28814

0.95

2.78

1.7

1.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

307

1579

1.22

2.76

1.3

1.4

10.99

11.24

umol/l

0.25

285

1517

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

176

848

1.30

2.76

1.2

1.3

11.95

12.26

u/l

0.13

161

778

(3003888) Timothy IgE Ab [Units/volume] in Serum

774

5462

0.89

2.76

1.1

4.05

5.63

u/ml

2.35

367

2883

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

411

3033

0.85

2.75

2.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

405

2141

1.19

2.73

1.6

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

106

1.89

2.69

1.1

1.20

1.22

u/field

0.05

(3023383) Lactate [Moles/volume] in Pleural fluid

370

1.46

2.69

1.3

3.38

3.28

mmol/l

0.12

342

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

210

1040

1.27

2.67

1.0

794.47

738.51

ng/l

1.13

156

717

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

311

1609

1.21

2.66

1.1

1.2

1.08

1.06

ratio

1.28

105

588

(3008401) Mugwort IgE Ab [Units/volume] in Serum

737

5202

0.89

2.65

1.1

1.30

1.08

u/ml

0.40

289

2264

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

404

2142

1.18

2.65

1.6

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

602

3292

1.15

2.64

1.8

2.55

6.22

titre

0.71

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

319

1656

1.21

2.64

1.7

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

139

1.76

2.63

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

107

1.87

2.63

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.12

2.62

1.0

1.1

195.88

225.55

pmol/l

0.14

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

173

839

1.29

2.61

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

173

839

1.29

2.61

1.3

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

266

1.53

2.60

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

210

1045

1.26

2.58

1.0

38.87

42.58

ng/l

0.60

159

730

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

646

3557

1.14

2.58

1.1

121.95

120.17

0.71

584

3212

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

119

549

1.36

2.54

1.1

68.79

73.74

0.25

113

(3026726) Creatinine [Moles/volume] in Specimen

113

1.83

2.54

1.4

2.6

526.70

393.02

umol/l

0.23

108

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

100

1.88

2.50

1.1

52.76

62.89

u/l

0.28

(3024869) Neuronal Ab [Presence] in Serum

294

1.49

2.50

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

167

812

1.29

2.49

4.1

2.9

—

(3035880) pH of Pleural fluid

140

665

1.32

2.47

1.2

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

419

1.41

2.47

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

300

1.48

2.46

3.5

2.5

0.76

1.48

mmol/l

2.09

222

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

673

3730

1.13

2.45

1.3

1.2

5.13

3.86

u/ml

1.06

280

1645

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

215

1.57

2.45

3.3

2.8

—

(3028717) Thiamine [Mass/volume] in Blood

220

1.57

2.44

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

220

1.57

2.44

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

148

1.69

2.40

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

282

1.49

2.38

1.4

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

303

1.47

2.36

1.2

1.4

43.23

61.95

ng/l

0.72

179

(3051651) Icteric interference index of Serum or Plasma

237

1210

1.23

2.35

3.4

3.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

693

3860

1.13

2.34

2.3

91.09

88.86

ug/min

0.04

390

2328

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

308

1616

1.19

2.32

2.5

2.6

514.14

537.43

e6/l

0.28

258

1334

(3006598) pH of Arterial cord blood

166

0.41

2.30

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

462

2510

1.15

2.28

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

3.13

2.28

1.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

220

1.54

2.24

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

286

1.47

2.24

1.3

1.2

600.99

248.83

ug/l

0.46

167

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

216

1.54

2.21

1.2

1.3

17.52

15.51

nmol/l

0.28

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

1374

0.80

2.20

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

702

4905

0.89

2.19

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

137

662

1.30

2.19

8.6

9.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

299

1575

1.19

2.18

2.6

0.21

0.22

e9/l

0.20

259

1333

(3023420) DNA double strand Ab [Units/volume] in Serum

488

2672

1.15

2.18

1.5

1.6

34.32

34.23

iu/ml

0.00

122

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

177

884

1.25

2.17

6.5

5.3

2498.90

5291.24

u/ml

0.27

148

(3041806) Other cells [#/volume] in Blood by Manual count

170

1328

0.80

2.15

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

179

897

1.25

2.14

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

376

2023

1.17

2.14

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

372

2000

1.17

2.14

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

178

1.58

2.13

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

223

1.52

2.13

1.6

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.99

2.13

1.1

24.99

28.44

nmol/24h

—

(40768795) Lymph node Pathology biopsy report

379

2042

1.16

2.12

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

136

660

1.29

2.11

1.6

1.9

2695.67

42416.42

u/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

715

4019

1.12

2.11

1.1

3.22

2.79

u/ml

0.38

323

2010

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

372

2003

1.16

2.10

1.1

1.2

—

(3008898) HLA-B27 [Presence]

1654

9660

1.07

2.10

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

100

465

1.35

2.09

1.3

1.4

44.39

40.26

0.45

316

(40759836) Histone Ab [Presence] in Serum by Immunoblot

371

1998

1.16

2.09

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

242

0.54

2.07

6.0

7.0

—

(3003129) Base excess in Capillary blood by calculation

381

1.38

2.06

1.6

1.7

0.37

0.85

mmol/l

0.46

363

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

374

2020

1.16

2.04

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

664

1.28

2.03

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

374

2021

1.16

2.03

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

393

1.37

2.02

1.5

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

226

1.50

2.02

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

877

4997

1.10

2.01

1.6

1.5

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

2.65

2.00

1.3

1.6

2890.00

3109.81

umol/l

0.05

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

150

744

1.26

1.99

2.8

2.9

28.08

28.67

umol/l

0.18

117

552

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

326

1.40

1.97

1.4

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

177

1.56

1.97

2.4

3.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

101

476

1.33

1.96

1.9

2.0

2.61

3.83

ug/l

0.48

306

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

269

1.44

1.96

1.2

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.87

1.95

1.9

2.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

360

1949

1.16

1.93

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

151

753

1.26

1.92

1.2

0.24

0.43

g/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

142

704

1.26

1.90

4.0

4.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

199

1.51

1.89

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

344

0.64

1.89

18.2

7.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

271

1.43

1.89

1.8

1.3

40.31

56.10

1.69

138

(3001964) Herpes simplex virus Ag [Presence] in Specimen

137

677

1.27

1.89

1.7

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

324

1744

1.16

1.88

1.5

42.47

33.95

3.08

195

1063

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

388

2779

0.87

1.87

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

346

1.38

1.85

1.8

2.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.98

1.79

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

359

1957

1.15

1.78

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.26

1.77

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

387

1.34

1.76

1.3

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

118

1.65

1.75

3.2

2.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

245

1.43

1.73

1.2

2.07

1.86

mmol/l

0.37

152

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

266

1.41

1.72

1.8

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

465

1.31

1.72

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

124

1.62

1.70

1.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

248

1320

1.18

1.69

1.5

19.51

22.96

u/ml

0.63

244

(3032868) Hemoglobin electrophoresis panel in Blood

205

1.47

1.68

1.5

1.6

—

(3048879) Bone marrow aspiration report

418

1.32

1.67

1.7

1.9

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.28

1.66

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

148

752

1.23

1.65

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

155

792

1.23

1.64

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

247

0.61

1.62

1.1

1.2

21.71

20.28

mmol/l

0.84

201

(3006576) Bicarbonate [Moles/volume] in Blood

108

530

1.28

1.62

5.4

6.0

24.74

25.03

mmol/l

0.31

490

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.86

1.61

1.0

1.1

0.67

1.15

u/field

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

3.91

1.61

1.6

6.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

125

625

1.25

1.61

3.0

3.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

146

1.54

1.61

1.2

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8571

54917

0.97

1.58

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

150

768

1.22

1.57

1.4

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.30

1.56

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.30

1.56

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.30

1.56

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.30

1.56

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.30

1.56

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.30

1.56

1.0

—

(3049233) Organic acids panel - Urine

2.00

1.55

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

297

2132

0.87

1.54

1.3

1.4

32.36

31.24

nmol/l

0.26

269

1957

(3011335) Digoxin [Mass/volume] in Serum or Plasma

113

1.61

1.53

2.2

2.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

536

3029

1.11

1.53

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

153

1.51

1.53

2.2

1.4

46.31

35.36

0.80

104

(3047007) Chlamydophila sp Ab [Presence] in Serum

672

3841

1.10

1.53

1.3

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

309

1690

1.15

1.51

2.6

2.9

39.23

54.50

mg/l

0.60

216

1186

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

447

1.29

1.51

1.4

61.94

61.93

0.00

373

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

134

1.54

1.48

2.4

1.4

18.38

11.19

0.67

100

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

122

941

0.81

1.48

1.0

1.1

9.09

11.78

u/ml

0.60

546

(3019897) Erythrocyte distribution width [Ratio] by Automated count

591

4064

0.91

1.47

2.7

2.4

13.28

13.12

3.16

586

4012

(3022475) Manganese [Moles/volume] in Blood

160

1.49

1.46

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

355

2505

0.89

1.44

1.4

8.61

7.60

mmol/l

3.78

337

2452

(3038177) Helicobacter pylori Ab [Presence] in Serum

735

4234

1.09

1.43

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.40

1.42

5.6

6.8

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.35

1.42

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

169

887

1.19

1.41

26.6

27.5

116.85

123.48

ug/l

0.53

138

743

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.92

1.41

1.7

1.4

163.00

131.53

nmol/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

141

1.51

1.41

1.1

20.26

25.11

u/l

0.88

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

203

1.42

1.41

1.6

1.3

—

(3007916) DNA double strand Ab [Titer] in Serum

294

1.34

1.39

1.3

1.4

240.00

96.00

titre

—

(3013762) Body weight Measured

1.79

1.39

1.0

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

209

1.41

1.38

1.0

1.1

7.50

3.39

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

178

1.44

1.37

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

232

1254

1.16

1.37

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

664

3817

1.09

1.37

1.1

—

(3006462) Nitrate [Presence] in Urine

203

1086

1.17

1.37

3.8

2.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

860

4998

1.08

1.36

1.3

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

112

1.57

1.36

2.0

1.3

0.38

1.82

2.25

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

453

2558

1.11

1.35

2.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

144

749

1.20

1.34

2.1

59.19

102.23

ug/min

0.48

146

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

169

1.45

1.33

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

379

1.29

1.32

1.4

2.31

2.60

0.12

320

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

110

845

0.81

1.32

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

121

620

1.22

1.31

1.5

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.91

1.30

3.6

3.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

380

0.72

1.30

18.3

7.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

255

1.35

1.29

1.0

—

(4212803) Bone marrow aspirate examination

134

1.50

1.29

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

673

3885

1.09

1.28

1.2

3.14

3.60

u/ml

0.28

194

1328

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.94

1.27

1.8

1.3

—

(3002619) Bacteria identified in Specimen by Culture

415

1.27

1.26

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

141

1.47

1.22

1.9

1.8

46.70

47.13

umol/l

0.03

141

(3026250) Tacrolimus [Mass/volume] in Blood

170

907

1.17

1.22

38.9

37.2

7.10

7.26

ug/l

0.50

154

839

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

819

4778

1.07

1.21

1.4

12.45

21.24

u/ml

2.08

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

227

1240

1.15

1.20

1.1

8.23

11.22

u/ml

0.67

222

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1903

11389

1.05

1.19

1.4

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

230

1259

1.14

1.18

1.2

16.84

12.46

u/ml

0.16

134

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

347

1.28

1.18

2.2

2.5

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

137

1.46

1.18

1.1

1.2

25.83

22.76

—

(3003694) ABO and Rh group [Type] in Blood

10685

68016

0.98

1.17

1.5

1.6

—

(3013862) HLA-DP [Type]

1.63

1.15

1.1

1.0

—

(3003338) MCHC [Mass/volume]

31436

197925

0.98

1.12

19.6

15.0

331.03

332.03

g/l

72.96

31221

196398

(3004775) Volume in Urine collected for unspecified duration

223

1224

1.14

1.12

2.2

2.3

674.46

627.90

0.82

151

886

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

823

4821

1.07

1.11

1.5

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

290

1620

1.12

1.11

2.2

2.0

2.49

2.46

u/field

0.03

138

706

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

296

1.29

1.09

5.2

4.4

49.84

34.79

ug/min

0.88

212

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

304

1706

1.12

1.08

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1686

10092

1.05

1.08

1.3

212.79

225.58

miu/ml

0.75

706

5037

(3015076) Soybean IgE Ab [Units/volume] in Serum

238

1682

0.89

1.07

1.0

0.62

1.07

u/ml

0.54

437

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

972

1.15

1.06

1.4

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

325

1.27

1.06

1.5

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

148

793

1.17

1.05

2.3

456.81

221.64

e6/l

0.52

451

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

276

1.29

1.04

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

495

1.21

1.04

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

495

1.21

1.04

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

495

1.21

1.04

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

495

1.21

1.04

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

227

1.32

1.04

11.6

10.2

4.83

5.28

mmol/l

0.78

227

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

163

882

1.16

1.02

1.1

518.33

490.21

ng/l

0.03

198

(40760410) HLA-B [Type] by High resolution

1.59

1.02

1.1

1.0

—

(40760409) HLA-A [Type] by High resolution

1.59

1.02

1.1

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

248

0.71

1.02

1.0

1.1

0.11

0.80

u/ml

—

155

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

109

812

0.84

1.01

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

272

1.29

1.01

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

116

1.46

1.01

3.1

4.8

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

1.00

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

266

1491

1.12

0.99

1.1

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

218

1.32

0.99

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

232

0.70

0.99

1.1

1.4

5.89

7.59

mmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

175

1.36

0.98

2.2

3.2

1.50

1.31

mg/l

0.12

121

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.51

0.98

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

202

0.68

0.98

1.0

7.57

19.34

u/ml

2.21

167

(46236302) HLA-C [Type] by High resolution typing

1.57

0.97

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

1.57

0.97

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

437

1.22

0.96

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

804

4735

1.06

0.96

1.3

261.37

261.18

u/ml

0.01

522

3034

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

760

4468

1.07

0.96

1.5

1.4

122.13

109.72

u/ml

0.94

167

991

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

225

1.31

0.95

1.2

1.1

1.49

1.62

umol/24h

0.56

225

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

525

0.81

0.93

1.2

1.1

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.65

0.93

3.7

2.4

42.35

35.60

umol/l

0.50

(3000492) Spirometry study

3604

21963

1.03

0.93

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

149

809

1.15

0.92

3.7

4.1

1328.13

2176.02

mg/l

0.25

106

589

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.81

0.92

1.3

1.1

1.82

2.32

0.53

(40757373) Influenza virus identified in Isolate

350

1.23

0.90

1.6

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

169

928

1.14

0.90

1.5

2.97

4.16

0.53

215

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

322

1.24

0.90

1.1

—

(3022689) Creatine [Moles/volume] in Urine

104

550

1.18

0.90

1.3

1.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

206

1.31

0.88

2.1

2.9

6.99

8.83

0.18

(3045683) HLA typing for celiac disease panel - Blood or Tissue

298

1695

1.10

0.88

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

257

1.27

0.86

1.2

1.1

—

(3022670) pH of Venous cord blood

0.51

0.85

1.0

1.1

—

(3017704) Immunofixation for Urine

155

850

1.14

0.85

1.5

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

184

1021

1.13

0.85

2.4

11.39

10.80

0.23

175

963

(3016750) Collection duration of Urine

173

957

1.13

0.84

2.2

2.1

503.80

503.54

min

0.01

128

745

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

462

1.19

0.84

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

300

2056

0.91

0.82

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

127

1.38

0.82

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

160

883

1.14

0.81

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

109

587

1.16

0.79

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

104

558

1.17

0.79

1.4

39.44

51.69

2.54

477

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

141

0.67

0.78

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

163

0.69

0.78

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

363

2098

1.08

0.78

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.46

0.78

1.1

1.0

—

(3034426) Prothrombin time (PT)

147

810

1.14

0.78

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

183

1.30

0.78

1.1

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

455

2654

1.07

0.77

1.1

1.56

2.02

iu/ml

—

(3011436) Histone Ab [Units/volume] in Serum

490

1.18

0.76

1.1

—

26.78

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1198

7191

1.04

0.76

1.6

1.92

6.24

iu/ml

0.64

241

1458

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.66

0.74

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

2.09

0.74

1.2

1.7

—

(3020491) Glucose [Moles/volume] in Blood

242

1664

0.91

0.74

1.9

1.7

6.50

6.31

mmol/l

0.46

168

1259

(3013247) Albumin in CSF/Albumin in Serum or Plasma

109

591

1.16

0.74

1.1

6.32

5.69

mg/g

0.53

564

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

707

4193

1.06

0.73

1.1

16.43

10.82

au/ml

0.66

280

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

175

982

1.12

0.71

2.2

2.3

27.11

28.14

0.52

170

941

(3001019) Free T4 and TSH panel - Serum or Plasma

2471

15900

0.97

0.71

1.7

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

159

1.30

0.69

1.5

1.3

1.44

1.93

ml/s/173m2

0.45

106

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

232

1.24

0.68

3.3

37.77

41.42

umol/l

0.60

197

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

204

1.26

0.68

4.9

4.6

2.15

2.38

mg/l

0.31

173

(3003740) Influenza virus B Ag [Presence] in Specimen

665

4386

0.95

0.67

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

280

1901

0.92

0.67

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

193

0.75

0.66

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

284

0.79

0.66

2.4

2.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

214

0.76

0.66

1.1

3.53

9.48

u/ml

2.59

149

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.60

0.65

1.0

1.3

—

12425.00

—

(3002523) Influenza virus A Ag [Presence] in Specimen

665

4382

0.95

0.65

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.58

0.64

1.0

3.42

12.96

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

297

1.20

0.63

1.3

39.07

39.89

mg/l

0.05

254

(3046861) Legionella sp Ag [Presence] in Urine

1.40

0.63

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

112

1.34

0.63

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.51

0.61

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.42

0.61

10.9

7.9

—

(3003577) Lead [Moles/volume] in Blood

140

0.72

0.61

1.3

1.4

0.18

0.21

umol/l

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

132

0.71

0.59

1.5

1.3

1.41

1.61

mg/l

—

112

(3032352) Blasts [#/volume] in Cerebral spinal fluid

221

1.22

0.56

1.6

3.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

296

1.18

0.56

1.5

1.4

20.69

24.36

0.49

249

(3048929) Epstein Barr virus Ab [Presence] in Serum

1356

8762

0.97

0.55

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.37

0.55

1.0

1.1

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.57

0.55

1.2

62.90

62.60

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

162

923

1.10

0.54

1.1

61.98

9.81

u/ml

0.42

554

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

121

1.29

0.54

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

436

2582

1.06

0.54

1.1

93.07

94.68

0.60

408

2419

(3033942) Copper [Moles/time] in 24 hour Urine

110

1.31

0.53

1.5

1.2

1.84

0.56

umol/24h

0.64

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.57

0.53

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

206

1.22

0.53

1.2

1.3

2.03

1.58

mmol/l

0.15

136

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

433

1.14

0.52

1.2

0.70

64.24

mg/l

2.51

313

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

130

899

0.91

0.51

1.8

2.0

8.76

9.55

mg/l

0.81

103

723

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

276

1.18

0.51

1.4

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

111

1.30

0.51

3.0

5.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

323

1.16

0.50

1.5

260878.62

305025.45

nmol/l

0.08

259

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

232

0.81

0.50

1.0

0.20

1.82

u/ml

2.00

150

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

179

1.22

0.50

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

117

1.28

0.50

1.3

110.65

103.63

ug/l

0.06

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

370

1.15

0.50

6.2

6.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.57

0.49

1.0

1.5

—

(36303858) Crystals [Presence] in Urine

1.57

0.49

1.1

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.34

0.49

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

151

1.24

0.49

1.1

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

140

962

0.91

0.49

1.2

—

(40765096) Chromosome analysis panel by Banding

442

1.13

0.48

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

472

1.13

0.47

1.3

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

502

1.12

0.47

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

3.46

2.03

mg/l

0.62

174

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

1.87

1.71

mg/l

0.07

168

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

0.98

1.01

mg/l

0.02

150

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

4.46

2.63

mg/l

0.73

166

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

3.86

4.06

mg/l

0.07

157

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

1.32

2.58

mg/l

1.45

160

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

3.33

2.98

mg/l

0.12

168

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

2.00

1.89

mg/l

0.06

146

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

239

1.18

0.45

1.6

1.7

1.62

0.96

mg/l

0.31

159

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

417

0.87

0.45

2.2

2.6

—

(3017400) Magnesium [Moles/volume] in Urine

1.42

0.44

1.0

1.4

2.11

3.13

mmol/l

1.37

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.29

0.44

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.47

0.44

1.4

4.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

246

1.17

0.43

1.6

1.7

1.40

1.78

mg/l

0.25

163

(3019174) dRVVT (LA screen)

229

1.18

0.43

1.1

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.57

0.42

1.2

1.6

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.31

0.42

1.0

0.05

0.08

u/ml

0.20

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.34

0.42

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

341

0.86

0.42

1.2

1.4

—

(3041184) Isoniazid [Presence] in Urine

1.49

0.41

2.6

2.5

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

121

1.24

0.40

1.1

2.84

3.24

u/l

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

161

1.21

0.40

1.4

73.40

72.94

0.03

138

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

167

1.20

0.40

1.3

30.61

245.55

u/l

0.65

124

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.41

0.40

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

110

753

0.91

0.39

2.9

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

197

0.83

0.38

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

351

0.87

0.38

1.0

1.1

0.56

3.33

u/ml

2.43

274

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

121

0.78

0.38

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

193

1133

1.07

0.37

2.0

1.7

1.72

2.32

u/field

0.91

143

805

(3044009) aPTT.lupus sensitive (LA screen)

233

1.16

0.36

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

123

1.22

0.36

1.5

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

303

1805

1.05

0.36

1.1

7.42

8.10

iu/ml

0.17

440

(3027570) Oxalate [Moles/time] in 24 hour Urine

129

1.21

0.36

2.1

1.4

413.04

300.45

umol/24h

1.69

129

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

129

1.21

0.36

1.1

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

280

1845

0.95

0.35

1.0

1.1

10.60

5.16

u/ml

0.24

492

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.34

0.34

1.0

1598.33

1857.50

titre

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

160

0.82

0.34

1.0

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

200

1.16

0.33

1.1

3.20

1.79

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.31

0.33

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

564

1.09

0.32

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

195

1.16

0.32

1.3

1.4

11.74

10.09

0.14

106

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

136

912

0.93

0.32

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

496

0.91

0.31

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

496

0.91

0.31

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

496

0.91

0.31

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

202

1336

0.95

0.31

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

137

917

0.94

0.31

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

315

1889

1.04

0.30

1.3

0.80

2.07

u/ml

3.41

181

1023

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.29

0.30

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

556

3591

0.97

0.29

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3983

24672

1.01

0.29

2.0

1.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

140

933

0.94

0.28

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.27

0.28

1.2

286.13

272.59

nmol/l

0.07

(3025018) Bordetella pertussis Ab [Titer] in Serum

276

1656

1.04

0.27

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

401

1.09

0.27

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.21

0.27

1.6

1.5

0.00

0.10

u/l

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

402

1.09

0.26

1.1

1.0

0.42

0.18

u/ml

0.25

242

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

109

728

0.94

0.25

1.7

160.97

152.16

au/ml

0.05

(3045462) Protein/Creatinine [Ratio] in Urine

289

1.11

0.25

5.1

5.9

34.19

228.25

g/mol

0.63

268

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.70

0.24

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

129

852

0.95

0.22

1.8

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.28

0.22

1.1

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.22

0.22

7.3

6.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

583

3738

0.98

0.22

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.22

0.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3146

19517

1.01

0.20

1.8

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

197

1.11

0.20

1.0

0.15

1.56

u/ml

1.30

151

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

251

1.10

0.20

2.9

2.2

0.57

0.84

u/field

1.43

251

(3032743) Legionella sp IgG Ab [Presence] in Serum

126

1.14

0.20

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

391

1.07

0.19

1.6

1.3

—

(3024316) Viscosity of Plasma

1.18

0.19

1.1

1.5

1.35

1.55

mpas

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

200

1206

1.04

0.19

1.1

1676.46

1463.61

miu/ml

1.54

200

1206

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

109

1.15

0.18

1.7

1.8

—

(3032641) Amino acids panel - Urine

1.12

0.17

1.7

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

389

0.93

0.17

1.6

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

232

1407

1.03

0.17

1.8

1.9

—

(3024471) HLA-A [Type]

104

683

0.95

0.16

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

304

0.93

0.16

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

419

1.06

0.16

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

239

0.92

0.16

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

128

769

1.04

0.15

2.0

1.7

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.10

0.15

6.3

7.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

111

1.13

0.15

4.9

4.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

117

1.12

0.15

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.80

0.15

2.1

2.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.78

0.15

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

296

0.93

0.15

1.0

0.69

0.51

u/ml

0.11

158

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

328

0.94

0.14

1.0

0.12

0.89

u/ml

1.40

180

(3011841) English Walnut IgE Ab [Units/volume] in Serum

347

0.94

0.14

1.0

1.1

1.61

4.78

u/ml

0.79

270

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

424

0.95

0.14

1.3

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.20

0.14

1.0

1.1

1411.60

6192.67

ng/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

359

0.94

0.13

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

130

1.11

0.13

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

227

1.08

0.13

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

275

0.93

0.13

5.8

5.7

72.16

68.84

0.33

208

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

191

0.92

0.13

1.0

0.21

0.57

u/ml

0.90

171

(3042733) HLA Ab [Presence] in Serum

109

657

1.04

0.12

4.8

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

139

899

0.97

0.12

2.9

2.8

116.61

155.30

au/ml

0.40

131

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.17

0.12

1.1

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.14

0.11

1.1

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

343

0.95

0.11

1.0

0.07

0.21

u/ml

1.19

203

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

585

0.96

0.11

1.1

1.71

8.31

u/ml

2.25

419

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

114

1.10

0.10

5.0

4.1

—

(40758358) Immune stain study

114

1.10

0.10

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

248

1522

1.02

0.10

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.16

0.10

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

124

0.91

0.10

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.11

0.10

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.12

0.10

1.2

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

145

1.08

0.09

1.1

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

102

619

1.03

0.09

1.1

8.30

2.81

u/ml

0.37

532

(40758292) HTLV I+II Ab panel - Serum

341

0.95

0.09

1.3

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

104

0.90

0.09

1.0

0.01

0.08

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

125

803

0.97

0.08

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.89

0.08

1.0

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.12

0.08

1.0

1.1

—

(3014891) Appearance of Pleural fluid

183

1.06

0.08

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.12

0.08

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

103

0.91

0.08

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

152

972

0.98

0.07

3.3

3.4

7.88

8.29

mg/l

0.33

121

777

(3050794) Legionella sp Ab [Presence] in Serum

167

0.94

0.07

1.2

1.1

—

(3024932) HLA-DR beta [Type]

103

662

0.97

0.07

1.2

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.08

0.07

1.0

—

(3001729) Color of Synovial fluid

147

1.06

0.07

1.8

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

100

642

0.98

0.07

1.6

1.7

9.41

8.71

ug/l

0.69

100

642

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.09

0.06

2.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

283

1.04

0.06

7.7

6.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.10

0.06

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

102

0.92

0.06

8.3

9.9

94.11

345.58

e6/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

240

1.04

0.06

3.1

3.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

142

1.06

0.05

1.1

8.96

10.67

u/l

0.27

142

(3025130) Human papilloma virus identified in Specimen

794

4943

1.01

0.05

1.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

196

0.96

0.04

1.2

1.1

0.74

1.65

u/ml

0.65

136

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.92

0.04

38.6

9.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

242

1.03

0.04

1.0

1.1

—

(3008607) Semen analysis panel

100

0.94

0.03

1.3

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

201

0.97

0.03

1.1

1.0

0.36

0.78

u/ml

0.37

119

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

333

0.98

0.03

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

305

1898

1.01

0.02

1.0

1.1

1.50

3.17

u/ml

0.90

117

657

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

332

0.98

0.02

1.0

0.36

1.75

u/ml

0.65

179

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

232

1.03

0.02

1.6

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.08

0.02

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

388

0.98

0.02

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

177

1101

1.01

0.01

1.3

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.93

0.01

1.0

—

1.07

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

327

2040

1.00

0.01

1.6

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

283

1.02

0.01

4.5

5.6

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.06

0.01

1.1

1.0

0.04

0.22

u/ml

—

(3015183) Erythrocyte sedimentation rate

218

1360

1.00

0.00

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

286

0.99

0.00

1.7

1.44

1.68

mg/l

0.56

244

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

110

0.97

0.00

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.01

0.00

1.0

1.3

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.03

0.00

1.4

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

139

0.99

0.00

1.0

0.51

11.35

u/ml

0.50

(3029612) Listeria sp Ab [Titer] in Serum

1.00

0.00

1.0

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

245

1532

1.00

0.00

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.98

0.00

1.1

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.98

0.00

1.1

1.0

0.10

0.27

u/ml

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.99

0.00

2.2

3.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

123

1.02

0.00

9.1

5.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

163

1.00

0.00

1.0

0.73

12.87

u/ml

0.49

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.98

0.00

1.1

1.0

0.08

0.38

u/ml

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.98

-0.00

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.96

-0.00

1.0

1.2

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.6

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.00

-0.00

2.1

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.02

-0.00

1.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.97

-0.00

1.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.95

-0.00

4.3

5.4

0.21

0.20

mmol/l

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.93

-0.00

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.92

-0.00

1.0

1.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.85

-0.00

1.0

1.1

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.88

-0.00

1.3

1.2

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

68.50

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.94

-0.00

1.3

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.00

-0.00

1.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_PCOS_CONSORTIUM_EXCLUSIONS – Exclusions for E4_PCOS_CONSORTIUM

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exclusions for E4_PCOS_CONSORTIUM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exclusions for E4_PCOS_CONSORTIUM (E4_PCOS_CONSORTIUM_EXCLUSIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints